<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="review-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title></journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2013.1168</article-id>
<article-id pub-id-type="publisher-id">ol-05-04-1101</article-id>
<article-categories>
<subj-group>
<subject>Review</subject></subj-group></article-categories>
<title-group>
<article-title>Role of the nervous system in cancer metastasis</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>LI</surname><given-names>SHA</given-names></name><xref rid="af1-ol-05-04-1101" ref-type="aff"><sup>1</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>SUN</surname><given-names>YANLAI</given-names></name><xref rid="af2-ol-05-04-1101" ref-type="aff"><sup>2</sup></xref><xref rid="af3-ol-05-04-1101" ref-type="aff"><sup>3</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>GAO</surname><given-names>DONGWEI</given-names></name><xref rid="af1-ol-05-04-1101" ref-type="aff"><sup>1</sup></xref><xref ref-type="corresp" rid="c1-ol-05-04-1101"/></contrib></contrib-group>
<aff id="af1-ol-05-04-1101">
<label>1</label>Department of Radiation Oncology, Lanzhou General Hospital of PLA, Lanzhou, Gansu 730050;</aff>
<aff id="af2-ol-05-04-1101">
<label>2</label>Department of Gastrointestinal Tumor Surgery, Shandong Cancer Hospital, Jinan, 250117;</aff>
<aff id="af3-ol-05-04-1101">
<label>3</label>Institute of Oncology, Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan 250021, 
<country>P.R. China</country></aff>
<author-notes>
<corresp id="c1-ol-05-04-1101">Correspondence to: Dr Dongwei Gao, Department of Radiation Oncology, Lanzhou General Hospital of PLA, 333 Southern Binhe Road, Lanzhou, Gansu 730050, P.R. China, E-mail: <email>gdw3152007@hotmail.com</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>4</month>
<year>2013</year></pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>01</month>
<year>2013</year></pub-date>
<volume>5</volume>
<issue>4</issue>
<fpage>1101</fpage>
<lpage>1111</lpage>
<history>
<date date-type="received">
<day>09</day>
<month>08</month>
<year>2012</year></date>
<date date-type="accepted">
<day>17</day>
<month>10</month>
<year>2012</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2013, Spandidos Publications</copyright-statement>
<copyright-year>2013</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>The notion that tumors lack innervation was proposed several years ago. However, nerve fibers are irregulatedly found in some tumor tissues. Their terminals interaction with cancer cells are considered to be neuro-neoplastic synapses. Moreover, neural-related factors, which are important players in the development and activity of the nervous system, have been found in cancer cells. Thus, they establish a direct connection between the nervous system and tumor cells. They modulate the process of metastasis, including degradation of base membranes, cancer cell invasion, migration, extravasation and colonization. Peripheral nerve invasion provides another pathway for the spread of cancer cells when blood and lymphatic metastases are absent, which is based on the interactions between the microenvironments of nerve fibers and tumor cells. The nervous system also modulates angiogenesis, the tumor microenvironment, bone marrow, immune functions and inflammatory pathways to influence metastases. Denervation of the tumor has been reported to enhance cancer metastasis. Stress, social isolation and other emotional factors may increase distant metastasis through releasing hormones from the brain, the hypothalamic-pituitary-adrenal axis and autonomic nervous system. Disruption of circadian rhythms will also promote cancer metastasis through direct and indirect actions of the nervous system. Therefore, the nervous system plays an important role in cancer metastasis.</p></abstract>
<kwd-group>
<kwd>nervous system</kwd>
<kwd>cancer metastasis</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="other">
<title>Contents</title>
<list list-type="order">
<list-item>
<p>Introduction</p></list-item>
<list-item>
<p>Search strategies and selection criteria</p></list-item>
<list-item>
<p>Connection, communication and interaction between the neural system and cancer cells</p></list-item>
<list-item>
<p>Nerve invasion is another route for cancer cell dissemination</p></list-item>
<list-item>
<p>The nervous system modulates angiogenesis and microenvironments in tumors to affect metastasis</p></list-item>
<list-item>
<p>Nervous system interacts with immune function and inflammation to influence cancer metastasis</p></list-item>
<list-item>
<p>Interactions between bone marrow and nervous system: implication for cancer metastasis</p></list-item>
<list-item>
<p>Cancer as an independent organ is being recognized and should not be isolated from the nervous system</p></list-item>
<list-item>
<p>Clinical and biological implications for the role of the nervous system in cancer metastasis</p></list-item>
<list-item>
<p>Conclusions</p></list-item></list></sec>
<sec sec-type="other">
<label>1.</label>
<title>Introduction</title>
<p>Since the 1970s, it has been generally accepted in the field of pathology that tumors lack innervation (<xref rid="b1-ol-05-04-1101" ref-type="bibr">1</xref>). However, the nervous system is a superordinate structure in the body and controls the functions and activities of virtually all other tissues and organs. Cancer tissues are not isolated structures within organisms, therefore they should also interact with the neural system. This speculation has been testified from clinical, epidemiological and experimental studies.</p>
<p>One the one hand, neural functions and tissues exert important functions on cancer initiation and development. Firstly, psychological and behavioral factors, such as chronic stress, depression and social isolation, are considered to contribute to the initiation and progression of certain types of cancer (<xref rid="b2-ol-05-04-1101" ref-type="bibr">2</xref>&#x02013;<xref rid="b6-ol-05-04-1101" ref-type="bibr">6</xref>). Stress is inevitable in human life. The brain is the key organ of the response to stress (<xref rid="b7-ol-05-04-1101" ref-type="bibr">7</xref>). In the whole brain, activation of the hypothalamic-pituitary-adrenal axis (HPA) plays an important role in the response (<xref rid="b2-ol-05-04-1101" ref-type="bibr">2</xref>,<xref rid="b7-ol-05-04-1101" ref-type="bibr">7</xref>). Thus, acting on certain areas in the brain has been reported to influence the growth and development of cancer (<xref rid="b8-ol-05-04-1101" ref-type="bibr">8</xref>&#x02013;<xref rid="b10-ol-05-04-1101" ref-type="bibr">10</xref>). Secondly, the peripheral nervous system is also involved in cancer. 6-Hydroxydopamine was shown to influence the growth rate of certain tumors (<xref rid="b11-ol-05-04-1101" ref-type="bibr">11</xref>) and induce neuronal changes on the sympathetic nervous system to augment the growth of neuroblastoma (<xref rid="b12-ol-05-04-1101" ref-type="bibr">12</xref>), suggesting that an intact functional sympathetic nervous system is necessary for certain tumors. Peripheral nerve fibers were found to innervate some tumors (<xref rid="b13-ol-05-04-1101" ref-type="bibr">13</xref>&#x02013;<xref rid="b16-ol-05-04-1101" ref-type="bibr">16</xref>). Neurons of dorsal root ganglia interact with cancer cells (<xref rid="b17-ol-05-04-1101" ref-type="bibr">17</xref>&#x02013;<xref rid="b19-ol-05-04-1101" ref-type="bibr">19</xref>). Denervation of a tumor also alters the behavior of tumor growth (<xref rid="b20-ol-05-04-1101" ref-type="bibr">20</xref>&#x02013;<xref rid="b22-ol-05-04-1101" ref-type="bibr">22</xref>). Peripheral nerve invasion (PNI) induced by cancer is an independent factor for poor prognosis in some cancer patients (<xref rid="b23-ol-05-04-1101" ref-type="bibr">23</xref>&#x02013;<xref rid="b26-ol-05-04-1101" ref-type="bibr">26</xref>).</p>
<p>On the other hand, cancer also has remote effects on neural tissues (<xref rid="b27-ol-05-04-1101" ref-type="bibr">27</xref>&#x02013;<xref rid="b29-ol-05-04-1101" ref-type="bibr">29</xref>). These facts indicate that there is a bidirectional correlation between the nervous system and cancer and challenge the traditional view that cancers lack innervation. Therefore, the role of the nervous system in cancer is gaining attention in cancer research (<xref rid="b5-ol-05-04-1101" ref-type="bibr">5</xref>, <xref rid="b29-ol-05-04-1101" ref-type="bibr">29</xref>&#x02013;<xref rid="b31-ol-05-04-1101" ref-type="bibr">31</xref>). Recently, the study by Sloan <italic>et al</italic>(<xref rid="b32-ol-05-04-1101" ref-type="bibr">32</xref>) study further showed that stress increases distant metastases but has little effect on primary tumor growth, prompting our interest in investigating the role of the nervous system in cancer metastasis.</p>
<p>It is well known that metastasis is the major cause of mortality from solid carcinomas. Despite great advances in metastasis research, the prognosis remains extremely poor. The formation of metastasis is a complex and sequential process, involving four basic steps: i) departure from the primary tumor, ii) survival in the circulatory system, iii) breaching of endothelium and basement membrane of target organs, and iv) establishment of a colony of metastatic cells (<xref rid="b33-ol-05-04-1101" ref-type="bibr">33</xref>). In these steps, immune functions, inflammation, organic microenvironments and bone marrow are involved (<xref rid="b34-ol-05-04-1101" ref-type="bibr">34</xref>&#x02013;<xref rid="b40-ol-05-04-1101" ref-type="bibr">40</xref>), all of which are directly or indirectly regulated by the nervous system. Thus, cancer metastasis may also establish connections with the nervous system through these pathophysiological changes and functional organs. Therefore, the nervous system may play an essential role in cancer metastasis. To gain a more comprehensive understanding of the role of the nervous system in cancer metastasis, we reviewed English-language literature on this topic and analyzed how the nervous system exerts its functions in cancer metastasis.</p></sec>
<sec sec-type="other">
<label>2.</label>
<title>Search strategies and selection criteria</title>
<p>The literature-based review was conducted by searching for keywords in Pubmed and Google Scholar using the search terms: &#x02018;cancer&#x02019;, &#x02018;tumor&#x02019;, &#x02018;neoplasm&#x02019;, &#x02018;malignant&#x02019;, &#x02018;metastasis&#x02019;, &#x02018;spread pathway&#x02019;, &#x02018;stress&#x02019;, &#x02018;depression&#x02019;, &#x02018;cancer-related neural disease&#x02019;, &#x02018;immune&#x02019;, &#x02018;inflammation&#x02019;, &#x02018;neuroendocrine&#x02019;, &#x02018;hypothalamic-pituitary-adrenal axis&#x02019;, &#x02018;innervation&#x02019;, &#x02018;nervous system&#x02019;, &#x02018;neurotransmitters&#x02019;, &#x02018;neurotrophic factors&#x02019;, &#x02018;semaphorins&#x02019;, &#x02018;psychoneuroimmunology&#x02019;, &#x02018;sympathetic&#x02019;, &#x02018;vagal&#x02019; and &#x02018;vagus&#x02019;. Only papers published in English prior to March 2012 and focusing on the association between the nervous system and cancer metastasis were included.</p></sec>
<sec sec-type="other">
<label>3.</label>
<title>Connection, communication and interaction between the neural system and cancer cells</title>
<p>The nervous system is formed of the central and peripheral nervous systems, which modulate the functions of the whole body through two main methods. The first is that they have a direct connection through a specific structure of classical or non-classical synapses. The other is that they interact with each other through humoral modulations. If the two methods are also found in cancer, the connection between the nervous system and cancer will be established.</p>
<p>Classical and non-classical synapse structures are the elements by which neurons innervate other tissues. Several lines of evidence also support the existence of these anatomical structures in tumor tissues. Nerve fibers have been found in certain tumor tissues, which may be due to i) the possibility of nerve fiber innervation vessels in cancer tissues, ii) the persistence of pre-existing nerves, or nerves becoming included within the cancer owing to the invasive character of its growth, iii) nerve endings growing into cancer tissue, or iv) an integral part of the cancerous growth (<xref rid="b41-ol-05-04-1101" ref-type="bibr">41</xref>). The first possibility was excluded in the study by Mitchell <italic>et al</italic>(<xref rid="b42-ol-05-04-1101" ref-type="bibr">42</xref>). Although the second possibility exists and often leads to cancer pain, this type of nerve fiber is surrounded by cancer tissues and hardly exerts any function on cancer cells. The latter two were also observed in previous studies. Nerve fibers in central tumor areas were observed by Seifert <italic>et al</italic>(<xref rid="b13-ol-05-04-1101" ref-type="bibr">13</xref>,<xref rid="b14-ol-05-04-1101" ref-type="bibr">14</xref>,<xref rid="b43-ol-05-04-1101" ref-type="bibr">43</xref>) using a transmission electron microscope. These nerve fibers in tumor tissues were irregularly distributed and had abnormal morphologies, which indicated that occurrences of these abnormal nerve fibers were accompanied with tumor tissues but not the pre-existing nerve fibers in corresponding normal tissues (<xref rid="b44-ol-05-04-1101" ref-type="bibr">44</xref>). Experimental studies showed that rectal cancer cells stimulated neurogenesis when they were cocultured with neuroepithelial cells (<xref rid="b18-ol-05-04-1101" ref-type="bibr">18</xref>). Thus, denervation by resection, capsaicin or vagotomy slows tumor growth (<xref rid="b20-ol-05-04-1101" ref-type="bibr">20</xref>&#x02013;<xref rid="b22-ol-05-04-1101" ref-type="bibr">22</xref>) and promotes cancer progression and metastasis (<xref rid="b45-ol-05-04-1101" ref-type="bibr">45</xref>&#x02013;<xref rid="b47-ol-05-04-1101" ref-type="bibr">47</xref>). These facts indicate that neuro-neoplastic synapses may exist between nerve fibers and tumor cells (<xref rid="b48-ol-05-04-1101" ref-type="bibr">48</xref>,<xref rid="b49-ol-05-04-1101" ref-type="bibr">49</xref>), and that neurogenesis, like angiogenesis, is also a trait of cancer cells (<xref rid="b18-ol-05-04-1101" ref-type="bibr">18</xref>,<xref rid="b48-ol-05-04-1101" ref-type="bibr">48</xref>,<xref rid="b50-ol-05-04-1101" ref-type="bibr">50</xref>,<xref rid="b51-ol-05-04-1101" ref-type="bibr">51</xref>). Thus, in primary and pre-metastatic organs, cancer cells actively establish connections with nerve fibers and receive signals from the nervous system.</p>
<p>Although the above studies indicated that tumor tissues were innervated, others do not support this theory (<xref rid="b42-ol-05-04-1101" ref-type="bibr">42</xref>,<xref rid="b52-ol-05-04-1101" ref-type="bibr">52</xref>,<xref rid="b53-ol-05-04-1101" ref-type="bibr">53</xref>). However, humoral modulation is the alternative means for the neural system to modulate other organs, which is also found in cancer. The axes of the systems of the HPA and autonomic nervous system (ANS) are typical pathways of humoral modulation through releasing hormones and neurotransmitters to bind corresponding receptors in other tissues to modulate functions of various tissues, including cancer. Thus, making lesions in these areas have significant effects on the behavior of cancer growth and metastasis. For example, Pollak <italic>et al</italic>(<xref rid="b54-ol-05-04-1101" ref-type="bibr">54</xref>) showed that hypophysectomy inhibited metastatic behavior in murine osteosarcoma. Function of the pineal gland and effect of spatial disorientation had an important influence on metastasis (<xref rid="b55-ol-05-04-1101" ref-type="bibr">55</xref>). These effects were mainly via humoral modulators, including neurotransmitters and neuropeptides, neurotrophic factors, semaphorins and other axon growth factors. These modulators of neural development and maintainence have been found to exert essential functions in cancer growth and development, and have been studied and reviewed by numerous authors (<xref rid="b56-ol-05-04-1101" ref-type="bibr">56</xref>&#x02013;<xref rid="b95-ol-05-04-1101" ref-type="bibr">95</xref>). Cancer cells also express these molecules and their receptors. For example, breast cancer cells can express &#x003B2;-endorphin (<xref rid="b96-ol-05-04-1101" ref-type="bibr">96</xref>), and transplantation of &#x003B2;-endorphin neurons into the hypothalamus inhibit the growth and metastasis of mammary carcinoma (<xref rid="b97-ol-05-04-1101" ref-type="bibr">97</xref>). Cancer cells also promote neurite formation through generating neutrophic factors and axon growth molecules (<xref rid="b98-ol-05-04-1101" ref-type="bibr">98</xref>). Thus, they will establish a connection with the nervous system through humoral modulation.</p>
<p>Thus, the existence of neuro-neoplastic synapses and receptors of neural markers in cancer cells provides a substantial basis for communication between neurons and cancer cells. Recent studies have shown that the nervous system influences the process of cancer metastasis through nerve endings and humoral modulations (<xref rid="b32-ol-05-04-1101" ref-type="bibr">32</xref>,<xref rid="b40-ol-05-04-1101" ref-type="bibr">40</xref>,<xref rid="b44-ol-05-04-1101" ref-type="bibr">44</xref>&#x02013;<xref rid="b47-ol-05-04-1101" ref-type="bibr">47</xref>,<xref rid="b58-ol-05-04-1101" ref-type="bibr">58</xref>,<xref rid="b67-ol-05-04-1101" ref-type="bibr">67</xref>,<xref rid="b75-ol-05-04-1101" ref-type="bibr">75</xref>&#x02013;<xref rid="b79-ol-05-04-1101" ref-type="bibr">79</xref>,<xref rid="b85-ol-05-04-1101" ref-type="bibr">85</xref>,<xref rid="b97-ol-05-04-1101" ref-type="bibr">97</xref>,<xref rid="b98-ol-05-04-1101" ref-type="bibr">98</xref>). For cancer cells to form metastases in ectopic sites, they must depart from the primary tumor and conquer the barriers of primary tissue inhibition. Proteolytic enzymes can help tumor cells escape from primary cancer; i.e. by degrading the surrounding normal tissues. In this process, the overexpression of matrix metalloproteinases (MMPs) in tumor cells is one of the most sustained events (<xref rid="b99-ol-05-04-1101" ref-type="bibr">99</xref>,<xref rid="b100-ol-05-04-1101" ref-type="bibr">100</xref>); this may be induced by stress, neural-related factors and neurotransmitters. For example, Wu <italic>et al</italic>(<xref rid="b101-ol-05-04-1101" ref-type="bibr">101</xref>) reported that stress due to social isolation enhanced invasion and metastasis of colon cancer cells through increasing proteolytic proteases. Yang <italic>et al</italic>(<xref rid="b102-ol-05-04-1101" ref-type="bibr">102</xref>) also found that stress modulates levels of MMPs through activation of the HPA and sympathetic-adrenal medullary (SAM) axes. Heregulin-&#x003B2;1 and nerve growth factor, as essential factors in the normal development of the nervous system, mediate the activation of MMP-9 and MMP-2 to promote invasion of breast cancer cells (<xref rid="b103-ol-05-04-1101" ref-type="bibr">103</xref>) and pancreatic cancer cells (<xref rid="b104-ol-05-04-1101" ref-type="bibr">104</xref>,<xref rid="b105-ol-05-04-1101" ref-type="bibr">105</xref>). Neurotrophins also promote invasion by enhancing the production of basement membrane-degradative enzymes (<xref rid="b106-ol-05-04-1101" ref-type="bibr">106</xref>). Norepinephrine (NE) and &#x003B3;-aminobutyric acid as classical neurotransmitters upregulate the expression of MMPs in nasopharyngeal cancer cells (<xref rid="b107-ol-05-04-1101" ref-type="bibr">107</xref>) and cancer cells of the prostate (<xref rid="b108-ol-05-04-1101" ref-type="bibr">108</xref>). Anoikis, a form of apoptosis, results from loss of cell-matrix interactions and acts as a physiological barrier to metastasis (<xref rid="b109-ol-05-04-1101" ref-type="bibr">109</xref>). Tropomyosin receptor kinase B (TrkB), a receptor of brain-derived neurotrophic factor (BDNF), induces cancer metastasis by suppression of anoikis (<xref rid="b110-ol-05-04-1101" ref-type="bibr">110</xref>&#x02013;<xref rid="b112-ol-05-04-1101" ref-type="bibr">112</xref>). Migration of cancer cells is a prerequisite for metastasis. Axon-guidance molecules, such as slits, semaphorins and netrins, can navigate or inhibit migration of cancer cells (<xref rid="b77-ol-05-04-1101" ref-type="bibr">77</xref>,<xref rid="b85-ol-05-04-1101" ref-type="bibr">85</xref>,<xref rid="b113-ol-05-04-1101" ref-type="bibr">113</xref>&#x02013;<xref rid="b117-ol-05-04-1101" ref-type="bibr">117</xref>). The neurotransmitter/receptor system is also involved in cancer cell migration (<xref rid="b118-ol-05-04-1101" ref-type="bibr">118</xref>). NE, a classical neurotransmitter, has a stimulatory effect on the migration of colon carcinoma cells (<xref rid="b119-ol-05-04-1101" ref-type="bibr">119</xref>) and breast cancer cells (<xref rid="b120-ol-05-04-1101" ref-type="bibr">120</xref>). A similar role was also reported for dopamine and neuropeptides, including met-enkephalin, substance P and bombesin (<xref rid="b120-ol-05-04-1101" ref-type="bibr">120</xref>). &#x003B3;-aminobutyric acid as an inhibitory neurotransmitter in the brain inhibits the migratory activity of colon carcinoma cells (<xref rid="b121-ol-05-04-1101" ref-type="bibr">121</xref>). Although these substances are also expressed in other organs (<xref rid="b122-ol-05-04-1101" ref-type="bibr">122</xref>) and tumor cells, inhibition of the activity of corresponding neurons can reverse their effects on cancer cells. For example, &#x003B2;-blockers acting on the ANS inhibit the migration of cancer cells induced by NE (<xref rid="b119-ol-05-04-1101" ref-type="bibr">119</xref>). Chemokines exerting important effects on neurogenesis and brain development (<xref rid="b123-ol-05-04-1101" ref-type="bibr">123</xref>,<xref rid="b124-ol-05-04-1101" ref-type="bibr">124</xref>) are also important modulators of cancer metastasis (<xref rid="b125-ol-05-04-1101" ref-type="bibr">125</xref>&#x02013;<xref rid="b127-ol-05-04-1101" ref-type="bibr">127</xref>). In the process of cancer cell migration through the blood system, 99.9&#x00025; of cancer cells are killed, which is called metastatic inefficiency (<xref rid="b128-ol-05-04-1101" ref-type="bibr">128</xref>). Mechanical forces including shear stress contribute to this inefficiency (<xref rid="b129-ol-05-04-1101" ref-type="bibr">129</xref>,<xref rid="b130-ol-05-04-1101" ref-type="bibr">130</xref>) while the shear force is mainly due to vasomotor changes. Nerve endings and receptors of neuropeptides are distributed in vascular walls (<xref rid="b131-ol-05-04-1101" ref-type="bibr">131</xref>). Based on the anatomical structures, the nervous system modulates the vascular functions, leading to changes in vascular dilation and constriction that can produce mechanical forces. Vascular permeability is important for cancer cell extravasation and colonization. Neuropeptides increase vascular permeability (<xref rid="b132-ol-05-04-1101" ref-type="bibr">132</xref>,<xref rid="b133-ol-05-04-1101" ref-type="bibr">133</xref>) to promote cancer cell extravasation and colonization. Thus, the process of cancer cell departure from the primary tumor, invasion, migration, cancer cell inefficiency, extravasation and colonization are associated with the nervous system.</p>
<p>Therefore, the connections between the neural system and cancer through synapse, non-synapse or humoral modulation make it possible to establish reciprocal interactions and communications between cancers and neurons.</p></sec>
<sec sec-type="other">
<label>4.</label>
<title>Nerve invasion is another route for cancer cell dissemination</title>
<p>Tumor dissemination from primary cancer is the first step in the formation of metastatic tumors at distant sites. Three major routes are considered to be involved in the spread of tumor cells: lymphatic vessels, blood vessels and serosal surfaces (<xref rid="b130-ol-05-04-1101" ref-type="bibr">130</xref>). The route of cancer cells along nerve fibers has been a forgotten pathway (<xref rid="b134-ol-05-04-1101" ref-type="bibr">134</xref>). Recently, PNI has been found in certain types of malignancies and identified to be another pathway for cancer cell dissemination, particularly in the absence of lymphatic or hematogenous metastasis (<xref rid="b26-ol-05-04-1101" ref-type="bibr">26</xref>). Although PNI has not been considered as a routine test in pathological reports, it has been identified as a key pathological feature in tumors and is used to predict clinical outcomes in many cancers (<xref rid="b18-ol-05-04-1101" ref-type="bibr">18</xref>,<xref rid="b23-ol-05-04-1101" ref-type="bibr">23</xref>&#x02013;<xref rid="b26-ol-05-04-1101" ref-type="bibr">26</xref>,<xref rid="b135-ol-05-04-1101" ref-type="bibr">135</xref>&#x02013;<xref rid="b143-ol-05-04-1101" ref-type="bibr">143</xref>).</p>
<p>It remains unknown what drives cancer cells to migrate along nerve fibers. In addition, since PNI has been accepted as an emerging route for cancer cell dissemination, PNI requires further definition. For the past 40 years, the predominant theory regarding the pathogenesis of PNI is that distributed tumor cells have the privilege of a low-resistance plane in the neural sheaths, which serves as a conduit for their migration. However, recent studies have shown that reciprocal signaling interactions between tumor cells and nerves may contribute to PNI. To explore these interactions, it is necessary to clarify the process of neurite formation. It has been shown that neurotrophic factors (NGF) and axonal guidance molecules are vital for axonal growth (<xref rid="b144-ol-05-04-1101" ref-type="bibr">144</xref>&#x02013;<xref rid="b149-ol-05-04-1101" ref-type="bibr">149</xref>). These molecules and their corresponding receptors are also found in tumor cells (<xref rid="b61-ol-05-04-1101" ref-type="bibr">61</xref>,<xref rid="b64-ol-05-04-1101" ref-type="bibr">64</xref>,<xref rid="b84-ol-05-04-1101" ref-type="bibr">84</xref>,<xref rid="b86-ol-05-04-1101" ref-type="bibr">86</xref>,<xref rid="b115-ol-05-04-1101" ref-type="bibr">115</xref>), which provide the possibility for cancer cells to bind to the neurite (<xref rid="b150-ol-05-04-1101" ref-type="bibr">150</xref>). In addition, stromal cells, extracellular matrix and their releasing factors are also involved in the process of axonal formation (<xref rid="b151-ol-05-04-1101" ref-type="bibr">151</xref>), and are also important for tumor cell migration. Thus, these tumor cells spreading along neural fibers may acquire the ability to respond to proinvasive signals within the peripheral nerve milieu and become neurotrophic. It is known that nerve fibers are composed of three layers, the epineurium, perineurium and endoneurium, from the outside to the inside. According to the definition of Liebig <italic>et al</italic>, when tumor cells are found within any of the three layers of the nerve sheath or tumor foci outside of the nerve with involvement of 33&#x00025; of the nerve&#x00027;s circumference, PNI may be diagnosed (<xref rid="b26-ol-05-04-1101" ref-type="bibr">26</xref>). This definition provides a new concept in the study of cancer cell dissemination.</p></sec>
<sec sec-type="other">
<label>5.</label>
<title>The nervous system modulates angiogenesis and microenvironments in tumors and affects metastasis</title>
<p>Angiogenesis is vital for the development of metastasis (<xref rid="b152-ol-05-04-1101" ref-type="bibr">152</xref>&#x02013;<xref rid="b154-ol-05-04-1101" ref-type="bibr">154</xref>). Vascular endothelial growth factor (VEGF) plays an important role in the process of angiogenesis. Several reports have demonstrated that psychological factors influence tumor angiogenesis in certain types of cancer through regulating of VEGF level. Chronic stress is common in cancer patients and often causes depression and bad moods. It has been reported that chronic stress mediates the vascularization of intraperitoneal metastasis and enhances tumor angiogenesis in the xenograft models of ovarian cancer via increasing VEGF expression (<xref rid="b155-ol-05-04-1101" ref-type="bibr">155</xref>,<xref rid="b156-ol-05-04-1101" ref-type="bibr">156</xref>). SNS can be activated in stressed animals (<xref rid="b155-ol-05-04-1101" ref-type="bibr">155</xref>) and may release neurotransmitters. These neurotransmitters, such as NE, dopamine and bradykinin, have been reported to induce or suppress VEGF expression (<xref rid="b132-ol-05-04-1101" ref-type="bibr">132</xref>,<xref rid="b158-ol-05-04-1101" ref-type="bibr">158</xref>&#x02013;<xref rid="b161-ol-05-04-1101" ref-type="bibr">161</xref>). Thus, the possible mechanism for chronic stress to enhance tumor angiogenesis may be that neurotransmitters released by activated SNS regulate VEGF expression to promote angiogenesis, which is also applicable to social isolation. It was reported that a perceived lack of social isolation was associated with elevated intratumoral NE in ovarian carcinoma patients. The elevated NE levels were correlated with high grade and advanced stage tumor (<xref rid="b162-ol-05-04-1101" ref-type="bibr">162</xref>) and indicated metastasis, which may be due to that NE induce VEGF expression and thus lead to stimulate angiogenesis (<xref rid="b158-ol-05-04-1101" ref-type="bibr">158</xref>). Other neural-related factors also have important effects on tumor angiogenesis. Axon growth molecules such as neuropilins and semaphorins can promote or inhibit angiogenesis (<xref rid="b63-ol-05-04-1101" ref-type="bibr">63</xref>,<xref rid="b86-ol-05-04-1101" ref-type="bibr">86</xref>,<xref rid="b163-ol-05-04-1101" ref-type="bibr">163</xref>&#x02013;<xref rid="b166-ol-05-04-1101" ref-type="bibr">166</xref>). A neuropeptide, calcitonin gene-related peptide (CGRP), can facilitate tumor-associated angiogenesis (<xref rid="b167-ol-05-04-1101" ref-type="bibr">167</xref>). Although it is expressed by other tissues, this experiment testifies that it is derived from neuronal systems. Neuropeptide Y also promotes angiogenesis through regulation of VEGF (<xref rid="b168-ol-05-04-1101" ref-type="bibr">168</xref>). Circadian rhythm is a basic regulator of normal physiology. Its disruption can also accelerate tumor growth through a Wnt signaling pathway (<xref rid="b169-ol-05-04-1101" ref-type="bibr">169</xref>), a critical pathway to regulate angiogenesis (<xref rid="b170-ol-05-04-1101" ref-type="bibr">170</xref>,<xref rid="b171-ol-05-04-1101" ref-type="bibr">171</xref>). Thus, the neural system is capable of modulating the process of angiogenesis. Moreover, neurogenesis also exists as a trait of certain types of cancer. Cancer cells also express these neural-related factors and their receptors. In fact, there are common molecules between angiogenesis and neurogenesis (<xref rid="b172-ol-05-04-1101" ref-type="bibr">172</xref>&#x02013;<xref rid="b174-ol-05-04-1101" ref-type="bibr">174</xref>), indicating that they may occur in concert in tumors and collectively exert functions on cancer metastasis (<xref rid="b175-ol-05-04-1101" ref-type="bibr">175</xref>).</p>
<p>The microenvironment regulates not only the growth of primary cancer but also the formation of metastasis, which is formed mainly of stromal cells and signal molecules. On the one hand, these cells and molecules have a direct or indirect correlation with the nervous system (<xref rid="b73-ol-05-04-1101" ref-type="bibr">73</xref>). Within the tumor microenvironment, stromal cells express &#x003B2;-adrenergic receptors that may be activated by neurotransmitters from local sympathetic nerve fibers and circulating blood. Macrophages in tumor microenvironments are important players in cancer metastasis, and are the key targets of &#x003B2;-adrenergic regulation in several cancer contexts (<xref rid="b73-ol-05-04-1101" ref-type="bibr">73</xref>). Certain molecules produced and released by neural tissues are the important origins of signals in the tumor microenvironment (<xref rid="b176-ol-05-04-1101" ref-type="bibr">176</xref>). However, stromal and tumor cells produce neural-related factors to stimulate neurite formation, receive nervous signals and act on the nervous system. Thus, cancer cells are able to take advantage of the factors produced by the nerve fibers to generate a positive microenvironment for cell survival and proliferation in the primary site and secondary organ. Therefore, the microenvironments and neural system establish a feedback loop. They also collectively contribute to the growth of primary cancer and the secondary tumor.</p></sec>
<sec sec-type="other">
<label>6.</label>
<title>Nervous system interacts with immune function and inflammation to influence cancer metastasis</title>
<p>The immune system has been identified to play a vital role in cancer metastasis (<xref rid="b35-ol-05-04-1101" ref-type="bibr">35</xref>,<xref rid="b177-ol-05-04-1101" ref-type="bibr">177</xref>,<xref rid="b178-ol-05-04-1101" ref-type="bibr">178</xref>). The association between the immune system and the nervous system has been widely studied and reviewed by many neurobiologists and immunologists (<xref rid="b179-ol-05-04-1101" ref-type="bibr">179</xref>,<xref rid="b180-ol-05-04-1101" ref-type="bibr">180</xref>). Several pathways are involved in the interaction between them. Among them, the neuroendocrine and neuronal pathways are the most significant, and are involved in the control of the humoral and cellular immune responses including the immunosuppressive effect, immunosurveillance and immunoenhancement. However, the immune system also influences the central nervous system. The bidirectional neural-immune interactions mainly occur through the neural and immune signal molecules including hormones, neurotransmitters, neuropeptides, cytokines or their receptors, all of which have been demonstrated to contribute to the process of metastasis (<xref rid="b181-ol-05-04-1101" ref-type="bibr">181</xref>&#x02013;<xref rid="b183-ol-05-04-1101" ref-type="bibr">183</xref>). Thus, the neural system modulates cancer metastasis through the immune system. For example, mood disorders, such as stress and depression, inhibit the immune system by decreasing cytotoxic T-cell and natural killer (NK) cells involved in innate immunity that can surveil for cancer metastasis (<xref rid="b2-ol-05-04-1101" ref-type="bibr">2</xref>). Therefore, stress enhances tumor metastasis via suppression of the immune system (<xref rid="b184-ol-05-04-1101" ref-type="bibr">184</xref>,<xref rid="b185-ol-05-04-1101" ref-type="bibr">185</xref>). It also has been identified that mood and relevant immunological status, along with important biological prognostic variables may contribute to the notable outcome variance in early-stage breast cancer (<xref rid="b186-ol-05-04-1101" ref-type="bibr">186</xref>). Circadian rhythm modulates the immune system by conveying timing information. Circadian disruption may lead to vulnerabilitys to infection and other diseases, including cancer (<xref rid="b187-ol-05-04-1101" ref-type="bibr">187</xref>,<xref rid="b188-ol-05-04-1101" ref-type="bibr">188</xref>). Therefore, the nervous system and its psychological or behavioral factors modulate metastasis through immune molecules, cells and effects (<xref rid="b189-ol-05-04-1101" ref-type="bibr">189</xref>).</p>
<p>The immune effect can induce an inflammatory response. However, unlike the association between the nervous system and immune system, the role of the nervous system in inflammation has only recently been described. It was also found that as well as controlling heart rate and other vital functions in real time, the nervous system reflexively regulates the inflammatory response (<xref rid="b190-ol-05-04-1101" ref-type="bibr">190</xref>,<xref rid="b191-ol-05-04-1101" ref-type="bibr">191</xref>). The vagus nerve, the arc of the reflex and neural-related factors such as netrin-1 and neuropeptides, are all involved in the control of inflammation (<xref rid="b131-ol-05-04-1101" ref-type="bibr">131</xref>,<xref rid="b192-ol-05-04-1101" ref-type="bibr">192</xref>&#x02013;<xref rid="b200-ol-05-04-1101" ref-type="bibr">200</xref>). Thus, the nervous system modulation of cancer development via inflammatory responses has been recognized. Inflammation has been thought to be a driving force for cancer metastasis (<xref rid="b36-ol-05-04-1101" ref-type="bibr">36</xref>). The inflammatory cells and pathways are the players in cancer metastasis. These players are reported to be influenced by the nervous system. Macrophages are key players not only for inflammation but also metastasis, and are regulated by neuromediators (<xref rid="b196-ol-05-04-1101" ref-type="bibr">196</xref>,<xref rid="b198-ol-05-04-1101" ref-type="bibr">198</xref>). Stress has been demonstrated to increase the level of IL-6 (<xref rid="b201-ol-05-04-1101" ref-type="bibr">201</xref>), which is a proinflammatory factor and plays an important role in cancer metastasis. NE and &#x003B2;-adrenergic receptors that can be induced by stress also regulate IL-6 (<xref rid="b202-ol-05-04-1101" ref-type="bibr">202</xref>,<xref rid="b203-ol-05-04-1101" ref-type="bibr">203</xref>). The transcription factor NF-&#x003BA;B is a significant inflammatory factor that has been identified to play a role in cancer development and metastasis (<xref rid="b183-ol-05-04-1101" ref-type="bibr">183</xref>,<xref rid="b204-ol-05-04-1101" ref-type="bibr">204</xref>). The neuronal guidance molecule netrin-1 is a direct transcriptional target of NF-&#x003BA;B and demonstrates upregulation under inflammatory conditions (<xref rid="b205-ol-05-04-1101" ref-type="bibr">205</xref>). Therefore, the nervous system modulates cancer metastasis through immunity and inflammation.</p></sec>
<sec sec-type="other">
<label>7.</label>
<title>Interactions between bone marrow and nervous system: implication for cancer metastasis</title>
<p>A recent discovery revealed the mechanism of bone marrow recruiting disseminated tumor cells (<xref rid="b206-ol-05-04-1101" ref-type="bibr">206</xref>). Moreover, it also plays an important role in sustaining tumor angiogenesis (<xref rid="b207-ol-05-04-1101" ref-type="bibr">207</xref>), microenvironment (<xref rid="b208-ol-05-04-1101" ref-type="bibr">208</xref>,<xref rid="b209-ol-05-04-1101" ref-type="bibr">209</xref>) and formation of the preniche for cancer cells arriving in pre-metastatic organs (<xref rid="b210-ol-05-04-1101" ref-type="bibr">210</xref>,<xref rid="b211-ol-05-04-1101" ref-type="bibr">211</xref>). Bone marrow recruits disseminated tumor cells by a recently discovered mechanism (<xref rid="b206-ol-05-04-1101" ref-type="bibr">206</xref>). It has been found that bone marrow can be innervated by the nervous system, including the ANS and noradrenergic sympathetic nerve fibers (<xref rid="b212-ol-05-04-1101" ref-type="bibr">212</xref>&#x02013;<xref rid="b216-ol-05-04-1101" ref-type="bibr">216</xref>). Preprotachykinin-I (PPT-I) peptides, a family of neuropeptides released by the ANS, are hematopoietic modulators and are highly expressed in cancer cells, which may explain the early integration of cancer cells in the bone marrow (<xref rid="b217-ol-05-04-1101" ref-type="bibr">217</xref>,<xref rid="b218-ol-05-04-1101" ref-type="bibr">218</xref>). Progenitor cells of bone marrow may contribute to tumor vascularization (<xref rid="b207-ol-05-04-1101" ref-type="bibr">207</xref>,<xref rid="b219-ol-05-04-1101" ref-type="bibr">219</xref>,<xref rid="b220-ol-05-04-1101" ref-type="bibr">220</xref>). The neurotransmitter dopamine regulates the process of mobilization of endothelial progenitor cells from bone marrow to tumor (<xref rid="b221-ol-05-04-1101" ref-type="bibr">221</xref>). Stromal cells of the bone marrow are an important source of tumor microenvironments (<xref rid="b222-ol-05-04-1101" ref-type="bibr">222</xref>), including formation of the pre-metastatic niche in metastatic organs. For example, tumor macrophages, which are derived from bone marrow, contribute to metastasis (<xref rid="b223-ol-05-04-1101" ref-type="bibr">223</xref>&#x02013;<xref rid="b225-ol-05-04-1101" ref-type="bibr">225</xref>). During migration, they are navigated by the nervous system (<xref rid="b226-ol-05-04-1101" ref-type="bibr">226</xref>&#x02013;<xref rid="b228-ol-05-04-1101" ref-type="bibr">228</xref>). Bone marrow stem cells play an important role in the repair of tissue injury, and are also thought to contribute to neurogenesis in cancer (<xref rid="b50-ol-05-04-1101" ref-type="bibr">50</xref>). They migrate from bone marrow to a terminal, then lodge and mature in the terminal under the control of the nervous system (<xref rid="b228-ol-05-04-1101" ref-type="bibr">228</xref>,<xref rid="b229-ol-05-04-1101" ref-type="bibr">229</xref>). Therefore, the role of bone marrow in cancer metastasis is modulated by the nervous system.</p></sec>
<sec sec-type="other">
<label>8.</label>
<title>Cancer as an independent organ is being recognized and should not be isolated from the nervous system</title>
<p>As cancer is formed of cancer cells and their surrouding tissues, and there are interactions between tumor cells and their micro- and macroenvironment, cancer is now being considered as a new organ or an independent structure in the body (<xref rid="b230-ol-05-04-1101" ref-type="bibr">230</xref>). Egeblad <italic>et al</italic>(<xref rid="b231-ol-05-04-1101" ref-type="bibr">231</xref>) considered tumors to be independent from other organs in the whole organism. This cancer organ is comprised of tumor cells, extracellular matrix, stromal cells and vessels. Although these components are abnormal, they can be organized into a new organ in a pathophysiological manner, which further exchanges and interacts with other organs. Thus, metastasis is viewed to be a result of the interactions between the tumor and the rest of the body. Mareel <italic>et al</italic>(<xref rid="b232-ol-05-04-1101" ref-type="bibr">232</xref>) viewed cancer as an ecosystem inside a living organism. The ecosystem comprises the primary tumor, lymph node and distant metastasis, bone marrow, blood and lymph circulation. The five elements constitute a vicious circle and interact with each other, finally leading to an influence on the whole system. Egeblad <italic>et al</italic> and Mareel <italic>et al</italic> had different views on cancer but shared the understanding that cancer is an independent system from other organ systems of the body. In this system, the components exchange information and communicate with other systems. However, these two views do not refer to the nerve system. It is well known that the constitutive elements of organs as well as microecosystems are all under the control of nervous system. In the process of metastasis, these elements exchange information with the nervous system. More importantly, the role of the neural system cannot be replaced by other systems. As a central system, it processes and stores information released by cancer cells. In clinical phenomena of cancer metastasis, metastatic tumors still resemble their primary cancers even after decades of dormancy. Comparisons between primary tumors and matched metastasis reveals similarities both at cancer cell and stromal levels, which may be modulated by the neural system.</p></sec>
<sec sec-type="other">
<label>9.</label>
<title>Clinical and biological implications for the role of nervous system in cancer metastasis</title>
<p>From the above findings, we can conclude that the neural system has an important influence on cancer metastasis. Stress, depression and social isolation as psychological factors have been reported to promote distant metastasis, which is due to them suppressing immune functions (<xref rid="b185-ol-05-04-1101" ref-type="bibr">185</xref>), promoting angiogenesis, activating macrophages and releasing proinflammatory factors, such as IL-6 (<xref rid="b201-ol-05-04-1101" ref-type="bibr">201</xref>) and TNF-&#x003B1; (<xref rid="b101-ol-05-04-1101" ref-type="bibr">101</xref>) and acting on the HPA and ANS (<xref rid="b3-ol-05-04-1101" ref-type="bibr">3</xref>,<xref rid="b233-ol-05-04-1101" ref-type="bibr">233</xref>) to release neurotransmitters (<xref rid="b234-ol-05-04-1101" ref-type="bibr">234</xref>). Circadian rhythm also influences distant metastasis through modulation of angiogenesis (<xref rid="b235-ol-05-04-1101" ref-type="bibr">235</xref>), the HPA and the immune system (<xref rid="b187-ol-05-04-1101" ref-type="bibr">187</xref>,<xref rid="b236-ol-05-04-1101" ref-type="bibr">236</xref>,<xref rid="b237-ol-05-04-1101" ref-type="bibr">237</xref>). The brain modulates cancer development including cancer metastasis through the vagus nerve (<xref rid="b45-ol-05-04-1101" ref-type="bibr">45</xref>). It has significant biological and clinical relevance.</p>
<p>Firstly, stress is a common phenomenon and prompts cancer metastasis, indicating that suppressing stress and modulating mood will be helpful for cancer patients (<xref rid="b234-ol-05-04-1101" ref-type="bibr">234</xref>,<xref rid="b238-ol-05-04-1101" ref-type="bibr">238</xref>). Thus, psychologically effective interventions on individuals with a variety of cancers can be resistant to cancer progression and improve clinical outcome for advanced cancer patients (<xref rid="b239-ol-05-04-1101" ref-type="bibr">239</xref>). Secondly, under circumstances without lymph node and blood metastasis, PNI offers another pathway for the spread of cancer cells. Determining the mechanism of PNI may provide additional options for the prevention and treatment of metastasis by inhibiting the pathway. Thirdly, neoangiogenesis and neurogenesis may exert their effects in concert on cancer metastasis. Inhibition of neoangiogenesis alone has little and even reverse effects on treating metastasis (<xref rid="b240-ol-05-04-1101" ref-type="bibr">240</xref>). For example, VEGF inhibitors have been reported to have no value in metastatic breast cancer (<xref rid="b241-ol-05-04-1101" ref-type="bibr">241</xref>) and even enhance metastasis in animal studies (<xref rid="b240-ol-05-04-1101" ref-type="bibr">240</xref>,<xref rid="b242-ol-05-04-1101" ref-type="bibr">242</xref>). Establishing the common molecules between the two types of genesis in cancer tissues and identify them as new targets is likely to aid in treating cancer metastasis. Fourthly, modulating the activities of the nervous system has an important influence on cancer metastasis. The brain is able to show functional or pathological changes when other organs in the whole organism are affected by cancer. The monitoring of these changes in the brain may be a new diagnostic approach to detect tumorigenesis and cancer recurrence. The vagus nerve is central in the response to extrinsic and intrinsic stressors and receiving the signals of the brain and other visceral organs, including cancer. Thus, inhibition of the activity of the vagus nerve is another strategy to prevent cancer metastasis (<xref rid="b243-ol-05-04-1101" ref-type="bibr">243</xref>&#x02013;<xref rid="b245-ol-05-04-1101" ref-type="bibr">245</xref>). For example, &#x003B2;-blockers are being considered to be a novel adjuvant to existing therapeutic strategies in clinical oncology (<xref rid="b73-ol-05-04-1101" ref-type="bibr">73</xref>). Finally, as important modulators in the nervous system and cancer, neurotrophic factors, neuropilins, axonal guidance molecules, neurotransmitters and their receptors are being considered to exploit new drugs to be used to treat metastasis (<xref rid="b78-ol-05-04-1101" ref-type="bibr">78</xref>,<xref rid="b82-ol-05-04-1101" ref-type="bibr">82</xref>,<xref rid="b111-ol-05-04-1101" ref-type="bibr">111</xref>,<xref rid="b165-ol-05-04-1101" ref-type="bibr">165</xref>,<xref rid="b234-ol-05-04-1101" ref-type="bibr">234</xref>,<xref rid="b246-ol-05-04-1101" ref-type="bibr">246</xref>&#x02013;<xref rid="b250-ol-05-04-1101" ref-type="bibr">250</xref>).</p>
<p>The study of metastasis is multifaceted (<xref rid="b251-ol-05-04-1101" ref-type="bibr">251</xref>). Numerous investigators have devoted themselves to metastasis from their own profession. Although their studies have made great advances, a number of questions remain to be addressed. The connection between the neural system and cancer that we propose in this review is not based on analogy of the association between the nervous system and the immune system but on current studies. The aim of this review was to aid individuals to gain a deeper understanding of cancer metastasis to a certain extent. Although it may not produce major breakthroughs in cancer metastsis, the role of the nervous system in cancer metastasis should not be neglected.</p></sec>
<sec sec-type="other">
<label>10.</label>
<title>Conclusions</title>
<p>In conclusion, the possible existing synapses in tumor cells and neural-related factors, such as neurotrophic factors and neurotransmitters, make it possible to establish direct connections between the nervous system and cancer. PNI offers another pathway for cancer cell distribution. On an anatomical basis, the nervous system is involved in the processes of metastasis, including tumor cell growth, proliferation, angiogenesis, apoptosis, departure from primary cancer, migration, extravasation and colonization, metastatic inefficiency, and modulators of cancer metastasis such as immunity, inflammation and bone marrow. Therefore, the nervous system plays an important role in cancer metastasis. Understanding its mechanism has important implications for exploring the biology of metastasis and the management of cancer metastasis.</p></sec></body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-ol-05-04-1101"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Willis</surname><given-names>RA</given-names></name></person-group><source>The Spread of Tumors in the Human Body</source><edition>3rd edition</edition><publisher-name>Butterworths</publisher-name><publisher-loc>London</publisher-loc><year>1973</year></element-citation></ref>
<ref id="b2-ol-05-04-1101"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiche</surname><given-names>EM</given-names></name><name><surname>Nunes</surname><given-names>SO</given-names></name><name><surname>Morimoto</surname><given-names>HK</given-names></name></person-group><article-title>Stress, depression, the immune system, and cancer</article-title><source>Lancet Oncol</source><volume>5</volume><fpage>617</fpage><lpage>625</lpage><year>2004</year></element-citation></ref>
<ref id="b3-ol-05-04-1101"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutgendorf</surname><given-names>SK</given-names></name><name><surname>Sood</surname><given-names>AK</given-names></name></person-group><article-title>Biobehavioral factors and cancer progression: physiological pathways and mechanisms</article-title><source>Psychosom Med</source><volume>73</volume><fpage>724</fpage><lpage>730</lpage><year>2011</year></element-citation></ref>
<ref id="b4-ol-05-04-1101"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thaker</surname><given-names>PH</given-names></name><name><surname>Sood</surname><given-names>AK</given-names></name></person-group><article-title>Neuroendocrine influences on cancer biology</article-title><source>Semin Cancer Biol</source><volume>18</volume><fpage>164</fpage><lpage>170</lpage><year>2008</year></element-citation></ref>
<ref id="b5-ol-05-04-1101"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armaiz-Pena</surname><given-names>GN</given-names></name><name><surname>Lutgendorf</surname><given-names>SK</given-names></name><name><surname>Cole</surname><given-names>SW</given-names></name><name><surname>Sood</surname><given-names>AK</given-names></name></person-group><article-title>Neuroendocrine modulation of cancer progression</article-title><source>Brain Behav Immun</source><volume>23</volume><fpage>10</fpage><lpage>15</lpage><year>2009</year></element-citation></ref>
<ref id="b6-ol-05-04-1101"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>JB</given-names></name><name><surname>Pang</surname><given-names>D</given-names></name><name><surname>Delgado</surname><given-names>B</given-names></name><name><surname>Kocherginsky</surname><given-names>M</given-names></name><name><surname>Tretiakova</surname><given-names>M</given-names></name><name><surname>Krausz</surname><given-names>T</given-names></name><name><surname>Pan</surname><given-names>D</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>McClintock</surname><given-names>MK</given-names></name><name><surname>Conzen</surname><given-names>SD</given-names></name></person-group><article-title>A model of gene-environment interaction reveals altered mammary gland gene expression and increased tumor growth following social isolation</article-title><source>Cancer Prev Res (Phila)</source><volume>2</volume><fpage>850</fpage><lpage>861</lpage><year>2009</year></element-citation></ref>
<ref id="b7-ol-05-04-1101"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McEwen</surname><given-names>BS</given-names></name></person-group><article-title>Physiology and neurobiology of stress and adaptation: central role of the brain</article-title><source>Physiol Rev</source><volume>87</volume><fpage>873</fpage><lpage>904</lpage><year>2007</year></element-citation></ref>
<ref id="b8-ol-05-04-1101"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toh</surname><given-names>YC</given-names></name></person-group><article-title>Inhibitory effect of hypothalamic lesions on liver tumor induction by N-2-fluorenylacetamide in male rats</article-title><source>Cancer Res</source><volume>38</volume><fpage>42</fpage><lpage>51</lpage><year>1978</year></element-citation></ref>
<ref id="b9-ol-05-04-1101"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karasek</surname><given-names>M</given-names></name><name><surname>Pawlikowski</surname><given-names>M</given-names></name></person-group><article-title>Pineal gland, melatonin and cancer. NEL Review</article-title><source>Neuro Endocrinol Lett</source><volume>20</volume><fpage>139</fpage><lpage>144</lpage><year>1999</year></element-citation></ref>
<ref id="b10-ol-05-04-1101"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruni</surname><given-names>JE</given-names></name><name><surname>Montemurro</surname><given-names>DG</given-names></name></person-group><article-title>Effect of hypothalamic lesions on the genesis of spontaneous mammary gland tumors in the mouse</article-title><source>Cancer Res</source><volume>31</volume><fpage>854</fpage><lpage>863</lpage><year>1971</year></element-citation></ref>
<ref id="b11-ol-05-04-1101"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chelmicka-Szorc</surname><given-names>E</given-names></name><name><surname>Arnason</surname><given-names>BG</given-names></name></person-group><article-title>Effect of 6-hydroxydopamine on tumor growth</article-title><source>Cancer Res</source><volume>36</volume><fpage>2382</fpage><lpage>2384</lpage><year>1976</year></element-citation></ref>
<ref id="b12-ol-05-04-1101"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chelmicka-Schorr</surname><given-names>E</given-names></name><name><surname>Arnason</surname><given-names>BG</given-names></name></person-group><article-title>Modulatory effect of the sympathetic nervous system on neuroblastoma tumor growth</article-title><source>Cancer Res</source><volume>38</volume><fpage>1374</fpage><lpage>1375</lpage><year>1978</year></element-citation></ref>
<ref id="b13-ol-05-04-1101"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seifert</surname><given-names>P</given-names></name><name><surname>Spitznas</surname><given-names>M</given-names></name></person-group><article-title>Tumours may be innervated</article-title><source>Virchows Arch</source><volume>438</volume><fpage>228</fpage><lpage>231</lpage><year>2001</year></element-citation></ref>
<ref id="b14-ol-05-04-1101"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seifert</surname><given-names>P</given-names></name><name><surname>Benedic</surname><given-names>M</given-names></name><name><surname>Effert</surname><given-names>P</given-names></name></person-group><article-title>Nerve fibers in tumors of the human urinary bladder</article-title><source>Virchows Arch</source><volume>440</volume><fpage>291</fpage><lpage>297</lpage><year>2002</year></element-citation></ref>
<ref id="b15-ol-05-04-1101"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>SH</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Que</surname><given-names>HP</given-names></name><name><surname>Liu</surname><given-names>SJ</given-names></name></person-group><article-title>Peptidergic innervation of human esophageal and cardiac carcinoma</article-title><source>World J Gastroenterol</source><volume>9</volume><fpage>399</fpage><lpage>403</lpage><year>2003</year></element-citation></ref>
<ref id="b16-ol-05-04-1101"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>YJ</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Wongba</surname><given-names>W</given-names></name><name><surname>Guardiola</surname><given-names>J</given-names></name><name><surname>Walker</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name></person-group><article-title>Pulmonary innervation, inflammation and carcinogenesis</article-title><source>Sheng Li Xue Bao</source><volume>62</volume><fpage>191</fpage><lpage>195</lpage><year>2010</year></element-citation></ref>
<ref id="b17-ol-05-04-1101"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JH</given-names></name><name><surname>Ma</surname><given-names>QY</given-names></name><name><surname>Shen</surname><given-names>SG</given-names></name><name><surname>Hu</surname><given-names>HT</given-names></name></person-group><article-title>Stimulation of dorsal root ganglion neurons activity by pancreatic cancer cell lines</article-title><source>Cell Biol Int</source><volume>32</volume><fpage>1530</fpage><lpage>1535</lpage><year>2008</year></element-citation></ref>
<ref id="b18-ol-05-04-1101"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albo</surname><given-names>D</given-names></name><name><surname>Akay</surname><given-names>CL</given-names></name><name><surname>Marshall</surname><given-names>CL</given-names></name><name><surname>Wilks</surname><given-names>JA</given-names></name><name><surname>Verstovsek</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Agarwal</surname><given-names>N</given-names></name><name><surname>Berger</surname><given-names>DH</given-names></name><name><surname>Ayala</surname><given-names>GE</given-names></name></person-group><article-title>Neurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes</article-title><source>Cancer</source><volume>117</volume><fpage>4834</fpage><lpage>4845</lpage><year>2011</year></element-citation></ref>
<ref id="b19-ol-05-04-1101"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayala</surname><given-names>GE</given-names></name><name><surname>Wheeler</surname><given-names>TM</given-names></name><name><surname>Shine</surname><given-names>HD</given-names></name><name><surname>Schmelz</surname><given-names>M</given-names></name><name><surname>Frolov</surname><given-names>A</given-names></name><name><surname>Chakraborty</surname><given-names>S</given-names></name><name><surname>Rowley</surname><given-names>D</given-names></name></person-group><article-title>In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer</article-title><source>Prostate</source><volume>49</volume><fpage>213</fpage><lpage>223</lpage><year>2001</year></element-citation></ref>
<ref id="b20-ol-05-04-1101"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batkin</surname><given-names>S</given-names></name><name><surname>Piette</surname><given-names>LH</given-names></name><name><surname>Wildman</surname><given-names>E</given-names></name></person-group><article-title>Effect of muscle denervation on growth of transplanted tumor in mice</article-title><source>Proc Natl Acad Sci USA</source><volume>67</volume><fpage>1521</fpage><lpage>1527</lpage><year>1970</year></element-citation></ref>
<ref id="b21-ol-05-04-1101"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papageorgiou</surname><given-names>A</given-names></name><name><surname>Trontzos</surname><given-names>C</given-names></name><name><surname>Kallistratos</surname><given-names>H</given-names></name><name><surname>Kokkas</surname><given-names>B</given-names></name><name><surname>Grigoriadis</surname><given-names>N</given-names></name><name><surname>Grammaticos</surname><given-names>P</given-names></name></person-group><article-title>Slowing growth and histology changes in Lewis lung carcinoma implanted in a partly denervated muscle</article-title><source>Cancer Invest</source><volume>21</volume><fpage>869</fpage><lpage>872</lpage><year>2003</year></element-citation></ref>
<ref id="b22-ol-05-04-1101"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romeo</surname><given-names>HE</given-names></name><name><surname>Colombo</surname><given-names>LL</given-names></name><name><surname>Esquifino</surname><given-names>AI</given-names></name><name><surname>Rosenstein</surname><given-names>RE</given-names></name><name><surname>Chuluyan</surname><given-names>HE</given-names></name><name><surname>Cardinali</surname><given-names>DP</given-names></name></person-group><article-title>Slower growth of tumours in sympathetically denervated murine skin</article-title><source>J Auton Nerv Syst</source><volume>32</volume><fpage>159</fpage><lpage>164</lpage><year>1991</year></element-citation></ref>
<ref id="b23-ol-05-04-1101"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Sheng</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Venook</surname><given-names>AP</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Guan</surname><given-names>Z</given-names></name><name><surname>Cai</surname><given-names>S</given-names></name></person-group><article-title>Perineural invasion in pT3N0 rectal cancer: the incidence and its prognostic effect</article-title><source>Cancer</source><volume>117</volume><fpage>1415</fpage><lpage>1421</lpage><year>2011</year></element-citation></ref>
<ref id="b24-ol-05-04-1101"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>FY</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Stenmark</surname><given-names>MH</given-names></name><name><surname>Halverson</surname><given-names>S</given-names></name><name><surname>Blas</surname><given-names>K</given-names></name><name><surname>Vance</surname><given-names>S</given-names></name><name><surname>Sandler</surname><given-names>HM</given-names></name><name><surname>Hamstra</surname><given-names>DA</given-names></name></person-group><article-title>Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy</article-title><source>Int J Radiat Oncol Biol Phys</source><volume>81</volume><fpage>e361</fpage><lpage>e367</lpage><year>2011</year></element-citation></ref>
<ref id="b25-ol-05-04-1101"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poeschl</surname><given-names>EM</given-names></name><name><surname>Pollheimer</surname><given-names>MJ</given-names></name><name><surname>Kornprat</surname><given-names>P</given-names></name><name><surname>Lindtner</surname><given-names>RA</given-names></name><name><surname>Schlemmer</surname><given-names>A</given-names></name><name><surname>Rehak</surname><given-names>P</given-names></name><name><surname>Vieth</surname><given-names>M</given-names></name><name><surname>Langner</surname><given-names>C</given-names></name></person-group><article-title>Perineural invasion: correlation with aggressive phenotype and independent prognostic variable in both colon and rectum cancer</article-title><source>J Clin Oncol</source><volume>28</volume><fpage>e358</fpage><lpage>e360</lpage><fpage>e361</fpage><lpage>e362</lpage><year>2010</year></element-citation></ref>
<ref id="b26-ol-05-04-1101"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liebig</surname><given-names>C</given-names></name><name><surname>Ayala</surname><given-names>G</given-names></name><name><surname>Wilks</surname><given-names>JA</given-names></name><name><surname>Berger</surname><given-names>DH</given-names></name><name><surname>Albo</surname><given-names>D</given-names></name></person-group><article-title>Perineural invasion in cancer: a review of the literature</article-title><source>Cancer</source><volume>115</volume><fpage>3379</fpage><lpage>3391</lpage><year>2009</year></element-citation></ref>
<ref id="b27-ol-05-04-1101"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khasraw</surname><given-names>M</given-names></name><name><surname>Posner</surname><given-names>JB</given-names></name></person-group><article-title>Neurological complications of systemic cancer</article-title><source>Lancet Neurol</source><volume>9</volume><fpage>1214</fpage><lpage>1227</lpage><year>2010</year></element-citation></ref>
<ref id="b28-ol-05-04-1101"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toothaker</surname><given-names>TB</given-names></name><name><surname>Rubin</surname><given-names>M</given-names></name></person-group><article-title>Paraneoplastic neurological syndromes: a review</article-title><source>Neurologist</source><volume>15</volume><fpage>21</fpage><lpage>33</lpage><year>2009</year></element-citation></ref>
<ref id="b29-ol-05-04-1101"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mravec</surname><given-names>B</given-names></name><name><surname>Gidron</surname><given-names>Y</given-names></name><name><surname>Hulin</surname><given-names>I</given-names></name></person-group><article-title>Neurobiology of cancer: Interactions between nervous, endocrine and immune systems as a base for monitoring and modulating the tumorigenesis by the brain</article-title><source>Semin Cancer Biol</source><volume>18</volume><fpage>150</fpage><lpage>163</lpage><year>2008</year></element-citation></ref>
<ref id="b30-ol-05-04-1101"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Entschladen</surname><given-names>F</given-names></name><name><surname>Palm</surname><given-names>D</given-names></name><name><surname>Niggemann</surname><given-names>B</given-names></name><name><surname>Zaenker</surname><given-names>KS</given-names></name></person-group><article-title>The cancer&#x00027;s nervous tooth: Considering the neuronal crosstalk within tumors</article-title><source>Semin Cancer Biol</source><volume>18</volume><fpage>171</fpage><lpage>175</lpage><year>2008</year></element-citation></ref>
<ref id="b31-ol-05-04-1101"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ondicova</surname><given-names>K</given-names></name><name><surname>Mravec</surname><given-names>B</given-names></name></person-group><article-title>Role of nervous system in cancer aetiopathogenesis</article-title><source>Lancet Oncol</source><volume>11</volume><fpage>596</fpage><lpage>601</lpage><year>2010</year></element-citation></ref>
<ref id="b32-ol-05-04-1101"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sloan</surname><given-names>EK</given-names></name><name><surname>Priceman</surname><given-names>SJ</given-names></name><name><surname>Cox</surname><given-names>BF</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Pimentel</surname><given-names>MA</given-names></name><name><surname>Tangkanangnukul</surname><given-names>V</given-names></name><name><surname>Arevalo</surname><given-names>JM</given-names></name><name><surname>Morizono</surname><given-names>K</given-names></name><name><surname>Karanikolas</surname><given-names>BD</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Sood</surname><given-names>AK</given-names></name><name><surname>Cole</surname><given-names>SW</given-names></name></person-group><article-title>The sympathetic nervous system induces a metastatic switch in primary breast cancer</article-title><source>Cancer Res</source><volume>70</volume><fpage>7042</fpage><lpage>7052</lpage><year>2010</year></element-citation></ref>
<ref id="b33-ol-05-04-1101"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>GP</given-names></name><name><surname>Massague</surname><given-names>J</given-names></name></person-group><article-title>Cancer metastasis: building a framework</article-title><source>Cell</source><volume>127</volume><fpage>679</fpage><lpage>695</lpage><year>2006</year></element-citation></ref>
<ref id="b34-ol-05-04-1101"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Visser</surname><given-names>KE</given-names></name><name><surname>Eichten</surname><given-names>A</given-names></name><name><surname>Coussens</surname><given-names>LM</given-names></name></person-group><article-title>Paradoxical roles of the immune system during cancer development</article-title><source>Nat Rev Cancer</source><volume>6</volume><fpage>24</fpage><lpage>37</lpage><year>2006</year></element-citation></ref>
<ref id="b35-ol-05-04-1101"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeNardo</surname><given-names>DG</given-names></name><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Coussens</surname><given-names>LM</given-names></name></person-group><article-title>Immune cells as mediators of solid tumor metastasis</article-title><source>Cancer Metastasis Rev</source><volume>27</volume><fpage>11</fpage><lpage>18</lpage><year>2008</year></element-citation></ref>
<ref id="b36-ol-05-04-1101"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>BP</given-names></name></person-group><article-title>Inflammation: a driving force speeds cancer metastasis</article-title><source>Cell Cycle</source><volume>8</volume><fpage>3267</fpage><lpage>3273</lpage><year>2009</year></element-citation></ref>
<ref id="b37-ol-05-04-1101"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solinas</surname><given-names>G</given-names></name><name><surname>Marchesi</surname><given-names>F</given-names></name><name><surname>Garlanda</surname><given-names>C</given-names></name><name><surname>Mantovani</surname><given-names>A</given-names></name><name><surname>Allavena</surname><given-names>P</given-names></name></person-group><article-title>Inflammation-mediated promotion of invasion and metastasis</article-title><source>Cancer Metastasis Rev</source><volume>29</volume><fpage>243</fpage><lpage>248</lpage><year>2010</year></element-citation></ref>
<ref id="b38-ol-05-04-1101"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>DX</given-names></name><name><surname>Bos</surname><given-names>PD</given-names></name><name><surname>Massague</surname><given-names>J</given-names></name></person-group><article-title>Metastasis: from dissemination to organ-specific colonization</article-title><source>Nat Rev Cancer</source><volume>9</volume><fpage>274</fpage><lpage>284</lpage><year>2009</year></element-citation></ref>
<ref id="b39-ol-05-04-1101"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>SY</given-names></name><name><surname>Hsieh</surname><given-names>CL</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Chung</surname><given-names>LW</given-names></name><name><surname>Johnstone</surname><given-names>PA</given-names></name></person-group><article-title>Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance</article-title><source>Curr Probl Cancer</source><volume>31</volume><fpage>36</fpage><lpage>100</lpage><year>2007</year></element-citation></ref>
<ref id="b40-ol-05-04-1101"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calorini</surname><given-names>L</given-names></name><name><surname>Bianchini</surname><given-names>F</given-names></name></person-group><article-title>Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions</article-title><source>Cell Commun Signal</source><volume>8</volume><fpage>24</fpage><year>2010</year></element-citation></ref>
<ref id="b41-ol-05-04-1101"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>DM</given-names></name><name><surname>Warren</surname><given-names>S</given-names></name></person-group><article-title>Cancer innervation</article-title><source>Cancer Res</source><volume>9</volume><fpage>707</fpage><lpage>711</lpage><year>1949</year></element-citation></ref>
<ref id="b42-ol-05-04-1101"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>BS</given-names></name><name><surname>Schumacher</surname><given-names>U</given-names></name><name><surname>Stauber</surname><given-names>VV</given-names></name><name><surname>Kaiserling</surname><given-names>E</given-names></name></person-group><article-title>Are breast tumours innervated? Immunohistological investigations using antibodies against the neuronal marker protein gene product 95 (PGP 95) in benign and malignant breast lesions</article-title><source>Eur J Cancer</source><volume>30A</volume><fpage>1100</fpage><lpage>1103</lpage><year>1994</year></element-citation></ref>
<ref id="b43-ol-05-04-1101"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seifert</surname><given-names>P</given-names></name><name><surname>Spitznas</surname><given-names>M</given-names></name></person-group><article-title>Axons in human choroidal melanoma suggest the participation of nerves in the control of these tumors</article-title><source>Am J Ophthalmol</source><volume>133</volume><fpage>711</fpage><lpage>713</lpage><year>2002</year></element-citation></ref>
<ref id="b44-ol-05-04-1101"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Tong</surname><given-names>L</given-names></name><name><surname>Yuan</surname><given-names>S</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Hong</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title>Substance P immunoreactive nerve fibres are related to gastric cancer differentiation status and could promote proliferation and migration of gastric cancer cells</article-title><source>Cell Biol Int</source><volume>35</volume><fpage>623</fpage><lpage>629</lpage><year>2011</year></element-citation></ref>
<ref id="b45-ol-05-04-1101"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gidron</surname><given-names>Y</given-names></name><name><surname>Perry</surname><given-names>H</given-names></name><name><surname>Glennie</surname><given-names>M</given-names></name></person-group><article-title>Does the vagus nerve inform the brain about preclinical tumours and modulate them?</article-title><source>Lancet Oncol</source><volume>6</volume><fpage>245</fpage><lpage>248</lpage><year>2005</year></element-citation></ref>
<ref id="b46-ol-05-04-1101"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erin</surname><given-names>N</given-names></name><name><surname>Boyer</surname><given-names>PJ</given-names></name><name><surname>Bonneau</surname><given-names>RH</given-names></name><name><surname>Clawson</surname><given-names>GA</given-names></name><name><surname>Welch</surname><given-names>DR</given-names></name></person-group><article-title>Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart</article-title><source>Anticancer Res</source><volume>24</volume><fpage>1003</fpage><lpage>1009</lpage><year>2004</year></element-citation></ref>
<ref id="b47-ol-05-04-1101"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erin</surname><given-names>N</given-names></name><name><surname>Akdas</surname><given-names>BG</given-names></name><name><surname>Harms</surname><given-names>JF</given-names></name><name><surname>Clawson</surname><given-names>GA</given-names></name></person-group><article-title>Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level</article-title><source>Regul Pept</source><volume>151</volume><fpage>35</fpage><lpage>42</lpage><year>2008</year></element-citation></ref>
<ref id="b48-ol-05-04-1101"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palm</surname><given-names>D</given-names></name><name><surname>Entschladen</surname><given-names>F</given-names></name></person-group><article-title>Neoneurogenesis and the neuroneoplastic synapse</article-title><source>Prog Exp Tumor Res</source><volume>39</volume><fpage>91</fpage><lpage>98</lpage><year>2007</year></element-citation></ref>
<ref id="b49-ol-05-04-1101"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanker</surname><given-names>KS</given-names></name></person-group><article-title>The neuro-neoplastic synapse: does it exist?</article-title><source>Prog Exp Tumor Res</source><volume>39</volume><fpage>154</fpage><lpage>161</lpage><year>2007</year></element-citation></ref>
<ref id="b50-ol-05-04-1101"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varner</surname><given-names>JA</given-names></name></person-group><article-title>Stem cells and neurogenesis in tumors</article-title><source>Prog Exp Tumor Res</source><volume>39</volume><fpage>122</fpage><lpage>129</lpage><year>2007</year></element-citation></ref>
<ref id="b51-ol-05-04-1101"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayala</surname><given-names>GE</given-names></name><name><surname>Dai</surname><given-names>H</given-names></name><name><surname>Powell</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Wheeler</surname><given-names>TM</given-names></name><name><surname>Shine</surname><given-names>D</given-names></name><name><surname>Kadmon</surname><given-names>D</given-names></name><name><surname>Thompson</surname><given-names>T</given-names></name><name><surname>Miles</surname><given-names>BJ</given-names></name><name><surname>Ittmann</surname><given-names>MM</given-names></name><name><surname>Rowley</surname><given-names>D</given-names></name></person-group><article-title>Cancer-related axonogenesis and neurogenesis in prostate cancer</article-title><source>Clin Cancer Res</source><volume>14</volume><fpage>7593</fpage><lpage>7603</lpage><year>2008</year></element-citation></ref>
<ref id="b52-ol-05-04-1101"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>BS</given-names></name><name><surname>Schumacher</surname><given-names>U</given-names></name><name><surname>Kaiserling</surname><given-names>E</given-names></name></person-group><article-title>Are tumours innervated? Immunohistological investigations using antibodies against the neuronal marker protein gene product 95 (PGP 95) in benign, malignant and experimental tumours</article-title><source>Tumour Biol</source><volume>15</volume><fpage>269</fpage><lpage>274</lpage><year>1994</year></element-citation></ref>
<ref id="b53-ol-05-04-1101"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terada</surname><given-names>T</given-names></name><name><surname>Matsunaga</surname><given-names>Y</given-names></name></person-group><article-title>S-100-positive nerve fibers in hepatocellular carcinoma and intrahepatic cholangiocarcinoma: an immunohistochemical study</article-title><source>Pathol Int</source><volume>51</volume><fpage>89</fpage><lpage>93</lpage><year>2001</year></element-citation></ref>
<ref id="b54-ol-05-04-1101"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollak</surname><given-names>M</given-names></name><name><surname>Sem</surname><given-names>AW</given-names></name><name><surname>Richard</surname><given-names>M</given-names></name><name><surname>Tetenes</surname><given-names>E</given-names></name><name><surname>Bell</surname><given-names>R</given-names></name></person-group><article-title>Inhibition of metastatic behavior of murine osteosarcoma by hypophysectomy</article-title><source>J Natl Cancer Inst</source><volume>84</volume><fpage>966</fpage><lpage>971</lpage><year>1992</year></element-citation></ref>
<ref id="b55-ol-05-04-1101"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giraldi</surname><given-names>T</given-names></name><name><surname>Perissin</surname><given-names>L</given-names></name><name><surname>Zorzet</surname><given-names>S</given-names></name><name><surname>Rapozzi</surname><given-names>V</given-names></name><name><surname>Rodani</surname><given-names>MG</given-names></name></person-group><article-title>Metastasis and neuroendocrine system in stressed mice</article-title><source>Int J Neurosci</source><volume>74</volume><fpage>265</fpage><lpage>278</lpage><year>1994</year></element-citation></ref>
<ref id="b56-ol-05-04-1101"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchetti</surname><given-names>B</given-names></name><name><surname>Spinola</surname><given-names>PG</given-names></name><name><surname>Pelletier</surname><given-names>G</given-names></name><name><surname>Labrie</surname><given-names>F</given-names></name></person-group><article-title>A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: hormonal control of beta-adrenergic receptors and correlation with tumor growth</article-title><source>J Steroid Biochem Mol Biol</source><volume>38</volume><fpage>307</fpage><lpage>320</lpage><year>1991</year></element-citation></ref>
<ref id="b57-ol-05-04-1101"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fava</surname><given-names>G</given-names></name><name><surname>Marucci</surname><given-names>L</given-names></name><name><surname>Glaser</surname><given-names>S</given-names></name><name><surname>Francis</surname><given-names>H</given-names></name><name><surname>De Morrow</surname><given-names>S</given-names></name><name><surname>Benedetti</surname><given-names>A</given-names></name><name><surname>Alvaro</surname><given-names>D</given-names></name><name><surname>Venter</surname><given-names>J</given-names></name><name><surname>Meininger</surname><given-names>C</given-names></name><name><surname>Patel</surname><given-names>T</given-names></name><name><surname>Taffetani</surname><given-names>S</given-names></name><name><surname>Marzioni</surname><given-names>M</given-names></name><name><surname>Summers</surname><given-names>R</given-names></name><name><surname>Reichenbach</surname><given-names>R</given-names></name><name><surname>Alpini</surname><given-names>G</given-names></name></person-group><article-title>Gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway</article-title><source>Cancer Res</source><volume>65</volume><fpage>11437</fpage><lpage>11446</lpage><year>2005</year></element-citation></ref>
<ref id="b58-ol-05-04-1101"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Wadei</surname><given-names>HA</given-names></name><name><surname>Plummer</surname><given-names>HK</given-names><suffix>III</suffix></name><name><surname>Schuller</surname><given-names>HM</given-names></name></person-group><article-title>Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid</article-title><source>Carcinogenesis</source><volume>30</volume><fpage>506</fpage><lpage>511</lpage><year>2009</year></element-citation></ref>
<ref id="b59-ol-05-04-1101"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>Y</given-names></name><name><surname>Mammoto</surname><given-names>T</given-names></name><name><surname>Kirita</surname><given-names>T</given-names></name><name><surname>Mukai</surname><given-names>M</given-names></name><name><surname>Mashimo</surname><given-names>T</given-names></name><name><surname>Sugimura</surname><given-names>M</given-names></name><name><surname>Kishi</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name></person-group><article-title>Epinephrine inhibits invasion of oral squamous carcinoma cells by modulating intra-cellular cAMP</article-title><source>Cancer Lett</source><volume>176</volume><fpage>143</fpage><lpage>148</lpage><year>2002</year></element-citation></ref>
<ref id="b60-ol-05-04-1101"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name></person-group><article-title>Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo</article-title><source>Life Sci</source><volume>82</volume><fpage>536</fpage><lpage>541</lpage><year>2008</year></element-citation></ref>
<ref id="b61-ol-05-04-1101"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>LM</given-names></name></person-group><article-title>The role of neuropilins in cancer</article-title><source>Mol Cancer Ther</source><volume>5</volume><fpage>1099</fpage><lpage>1107</lpage><year>2006</year></element-citation></ref>
<ref id="b62-ol-05-04-1101"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzolio</surname><given-names>S</given-names></name><name><surname>Tamagnone</surname><given-names>L</given-names></name></person-group><article-title>Multifaceted role of neuropilins in cancer</article-title><source>Curr Med Chem</source><volume>18</volume><fpage>3563</fpage><lpage>3575</lpage><year>2011</year></element-citation></ref>
<ref id="b63-ol-05-04-1101"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreuter</surname><given-names>M</given-names></name><name><surname>Bielenberg</surname><given-names>D</given-names></name><name><surname>Hida</surname><given-names>Y</given-names></name><name><surname>Hida</surname><given-names>K</given-names></name><name><surname>Klagsbrun</surname><given-names>M</given-names></name></person-group><article-title>Role of neuropilins and semaphorins in angiogenesis and cancer</article-title><source>Ann Hematol</source><volume>81</volume><issue>Suppl 2</issue><fpage>S74</fpage><year>2002</year></element-citation></ref>
<ref id="b64-ol-05-04-1101"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chedotal</surname><given-names>A</given-names></name><name><surname>Kerjan</surname><given-names>G</given-names></name><name><surname>Moreau-Fauvarque</surname><given-names>C</given-names></name></person-group><article-title>The brain within the tumor: new roles for axon guidance molecules in cancers</article-title><source>Cell Death Differ</source><volume>12</volume><fpage>1044</fpage><lpage>1056</lpage><year>2005</year></element-citation></ref>
<ref id="b65-ol-05-04-1101"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawara</surname><given-names>A</given-names></name></person-group><article-title>Trk receptor tyrosine kinases: a bridge between cancer and neural development</article-title><source>Cancer Lett</source><volume>169</volume><fpage>107</fpage><lpage>114</lpage><year>2001</year></element-citation></ref>
<ref id="b66-ol-05-04-1101"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>HP</given-names></name><name><surname>Ho</surname><given-names>JW</given-names></name><name><surname>Koo</surname><given-names>MW</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>WK</given-names></name><name><surname>Lam</surname><given-names>EK</given-names></name><name><surname>Tai</surname><given-names>EK</given-names></name><name><surname>Ko</surname><given-names>JK</given-names></name><name><surname>Shin</surname><given-names>VY</given-names></name><name><surname>Chu</surname><given-names>KM</given-names></name><name><surname>Cho</surname><given-names>CH</given-names></name></person-group><article-title>Effects of adrenaline in human colon adenocarcinoma HT-29 cells</article-title><source>Life Sci</source><volume>88</volume><fpage>1108</fpage><lpage>1112</lpage><year>2011</year></element-citation></ref>
<ref id="b67-ol-05-04-1101"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>YE</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name></person-group><article-title>Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development</article-title><source>J Mol Med (Berl)</source><volume>82</volume><fpage>735</fpage><lpage>749</lpage><year>2004</year></element-citation></ref>
<ref id="b68-ol-05-04-1101"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro-Rivera</surname><given-names>E</given-names></name><name><surname>Ran</surname><given-names>S</given-names></name><name><surname>Brekken</surname><given-names>RA</given-names></name><name><surname>Minna</surname><given-names>JD</given-names></name></person-group><article-title>Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells</article-title><source>Cancer Res</source><volume>68</volume><fpage>8295</fpage><lpage>8303</lpage><year>2008</year></element-citation></ref>
<ref id="b69-ol-05-04-1101"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kigel</surname><given-names>B</given-names></name><name><surname>Varshavsky</surname><given-names>A</given-names></name><name><surname>Kessler</surname><given-names>O</given-names></name><name><surname>Neufeld</surname><given-names>G</given-names></name></person-group><article-title>Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells</article-title><source>PLoS One</source><volume>3</volume><fpage>e3287</fpage><year>2008</year></element-citation></ref>
<ref id="b70-ol-05-04-1101"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pisick</surname><given-names>E</given-names></name><name><surname>Jagadeesh</surname><given-names>S</given-names></name><name><surname>Salgia</surname><given-names>R</given-names></name></person-group><article-title>Receptor tyrosine kinases and inhibitors in lung cancer</article-title><source>Scientific World Journal</source><volume>4</volume><fpage>589</fpage><lpage>604</lpage><year>2004</year></element-citation></ref>
<ref id="b71-ol-05-04-1101"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>JM</given-names></name></person-group><article-title>Potential inhibition of the neuro-neoplastic interactions: the clue of a GPCR-targeted therapy</article-title><source>Prog Exp Tumor Res</source><volume>39</volume><fpage>130</fpage><lpage>153</lpage><year>2007</year></element-citation></ref>
<ref id="b72-ol-05-04-1101"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>PJ</given-names></name></person-group><article-title>Is norepinephrine an etiological factor in some types of cancer?</article-title><source>Int J Cancer</source><volume>124</volume><fpage>257</fpage><lpage>263</lpage><year>2009</year></element-citation></ref>
<ref id="b73-ol-05-04-1101"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>SW</given-names></name><name><surname>Sood</surname><given-names>AK</given-names></name></person-group><article-title>Molecular pathways: beta-adrenergic signaling pathways in cancer</article-title><source>Clin Cancer Res</source><volume>18</volume><fpage>1201</fpage><lpage>1206</lpage><year>2011</year></element-citation></ref>
<ref id="b74-ol-05-04-1101"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Wadei</surname><given-names>HA</given-names></name><name><surname>Plummer</surname><given-names>HK</given-names><suffix>III</suffix></name><name><surname>Ullah</surname><given-names>MF</given-names></name><name><surname>Unger</surname><given-names>B</given-names></name><name><surname>Brody</surname><given-names>JR</given-names></name><name><surname>Schuller</surname><given-names>HM</given-names></name></person-group><article-title>Social stress promotes and &#x003B3;-aminobutyric acid inhibits tumor growth in mouse models of non-small cell lung cancer</article-title><source>Cancer Prev Res (Phila)</source><volume>5</volume><fpage>189</fpage><lpage>196</lpage><year>2012</year></element-citation></ref>
<ref id="b75-ol-05-04-1101"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casazza</surname><given-names>A</given-names></name><name><surname>Kigel</surname><given-names>B</given-names></name><name><surname>Maione</surname><given-names>F</given-names></name><name><surname>Capparuccia</surname><given-names>L</given-names></name><name><surname>Kessler</surname><given-names>O</given-names></name><name><surname>Giraudo</surname><given-names>E</given-names></name><name><surname>Mazzone</surname><given-names>M</given-names></name><name><surname>Neufeld</surname><given-names>G</given-names></name><name><surname>Tamagnone</surname><given-names>L</given-names></name></person-group><article-title>Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform</article-title><source>EMBO Mol Med</source><volume>4</volume><fpage>234</fpage><lpage>250</lpage><year>2012</year></element-citation></ref>
<ref id="b76-ol-05-04-1101"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erin</surname><given-names>N</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Bylander</surname><given-names>J</given-names></name><name><surname>Chase</surname><given-names>G</given-names></name><name><surname>Clawson</surname><given-names>G</given-names></name></person-group><article-title>Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells</article-title><source>Breast Cancer Res Treat</source><volume>99</volume><fpage>351</fpage><lpage>364</lpage><year>2006</year></element-citation></ref>
<ref id="b77-ol-05-04-1101"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasarre</surname><given-names>P</given-names></name><name><surname>Potiron</surname><given-names>V</given-names></name><name><surname>Drabkin</surname><given-names>H</given-names></name><name><surname>Roche</surname><given-names>J</given-names></name></person-group><article-title>Guidance molecules in lung cancer</article-title><source>Cell Adh Migr</source><volume>4</volume><fpage>130</fpage><lpage>145</lpage><year>2010</year></element-citation></ref>
<ref id="b78-ol-05-04-1101"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weick</surname><given-names>A</given-names></name><name><surname>Augustin</surname><given-names>HG</given-names></name></person-group><article-title>Double attack on tumors by targeting with guidance molecules</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>31</volume><fpage>721</fpage><lpage>722</lpage><year>2011</year></element-citation></ref>
<ref id="b79-ol-05-04-1101"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernet</surname><given-names>A</given-names></name><name><surname>Fitamant</surname><given-names>J</given-names></name></person-group><article-title>Netrin-1 and its receptors in tumour growth promotion</article-title><source>Expert Opin Ther Targets</source><volume>12</volume><fpage>995</fpage><lpage>1007</lpage><year>2008</year></element-citation></ref>
<ref id="b80-ol-05-04-1101"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuller</surname><given-names>HM</given-names></name><name><surname>Al-Wadei</surname><given-names>HA</given-names></name></person-group><article-title>Neurotransmitter receptors as central regulators of pancreatic cancer</article-title><source>Future Oncol</source><volume>6</volume><fpage>221</fpage><lpage>228</lpage><year>2010</year></element-citation></ref>
<ref id="b81-ol-05-04-1101"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novotny</surname><given-names>A</given-names></name><name><surname>Ryberg</surname><given-names>K</given-names></name><name><surname>Heiman</surname><given-names>UJ</given-names></name><name><surname>Nilsson</surname><given-names>L</given-names></name><name><surname>Khorram-Manesh</surname><given-names>A</given-names></name><name><surname>Nordgren</surname><given-names>S</given-names></name><name><surname>Delbro</surname><given-names>DS</given-names></name><name><surname>Nylund</surname><given-names>G</given-names></name></person-group><article-title>Is acetylcholine a signaling molecule for human colon cancer progression?</article-title><source>Scand J Gastroenterol</source><volume>46</volume><fpage>446</fpage><lpage>455</lpage><year>2011</year></element-citation></ref>
<ref id="b82-ol-05-04-1101"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Wadei</surname><given-names>HA</given-names></name><name><surname>Al-Wadei</surname><given-names>MH</given-names></name><name><surname>Schuller</surname><given-names>HM</given-names></name></person-group><article-title>Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention</article-title><source>PLoS One</source><volume>7</volume><fpage>e29915</fpage><year>2012</year></element-citation></ref>
<ref id="b83-ol-05-04-1101"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Wadei</surname><given-names>HA</given-names></name><name><surname>Ullah</surname><given-names>MF</given-names></name><name><surname>Al-Wadei</surname><given-names>M</given-names></name></person-group><article-title>GABA (&#x003B3;-aminobutyric acid), a non-protein amino acid counters the &#x003B2;-adrenergic cascade-activated oncogenic signaling in pancreatic cancer: a review of experimental evidence</article-title><source>Mol Nutr Food Res</source><volume>55</volume><fpage>1745</fpage><lpage>1758</lpage><year>2011</year></element-citation></ref>
<ref id="b84-ol-05-04-1101"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neufeld</surname><given-names>G</given-names></name><name><surname>Shraga-Heled</surname><given-names>N</given-names></name><name><surname>Lange</surname><given-names>T</given-names></name><name><surname>Guttmann-Raviv</surname><given-names>N</given-names></name><name><surname>Herzog</surname><given-names>Y</given-names></name><name><surname>Kessler</surname><given-names>O</given-names></name></person-group><article-title>Semaphorins in cancer</article-title><source>Front Biosci</source><volume>10</volume><fpage>751</fpage><lpage>760</lpage><year>2005</year></element-citation></ref>
<ref id="b85-ol-05-04-1101"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzolio</surname><given-names>S</given-names></name><name><surname>Tamagnone</surname><given-names>L</given-names></name></person-group><article-title>Semaphorin signals on the road to cancer invasion and metastasis</article-title><source>Cell Adh Migr</source><volume>1</volume><fpage>62</fpage><lpage>68</lpage><year>2007</year></element-citation></ref>
<ref id="b86-ol-05-04-1101"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Chai</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Fisher</surname><given-names>WE</given-names></name><name><surname>Yao</surname><given-names>Q</given-names></name></person-group><article-title>Roles of neuropilins in neuronal development, angiogenesis, and cancers</article-title><source>World J Surg</source><volume>29</volume><fpage>271</fpage><lpage>275</lpage><year>2005</year></element-citation></ref>
<ref id="b87-ol-05-04-1101"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Kariya</surname><given-names>M</given-names></name><name><surname>Higuchi</surname><given-names>T</given-names></name><name><surname>Mandai</surname><given-names>M</given-names></name><name><surname>Matsumura</surname><given-names>N</given-names></name><name><surname>Kondoh</surname><given-names>E</given-names></name><name><surname>Miyanishi</surname><given-names>M</given-names></name><name><surname>Fukuhara</surname><given-names>K</given-names></name><name><surname>Takakura</surname><given-names>K</given-names></name><name><surname>Fujii</surname><given-names>S</given-names></name></person-group><article-title>Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition</article-title><source>Gynecol Oncol</source><volume>105</volume><fpage>703</fpage><lpage>711</lpage><year>2007</year></element-citation></ref>
<ref id="b88-ol-05-04-1101"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warrington</surname><given-names>RJ</given-names></name><name><surname>Lewis</surname><given-names>KE</given-names></name></person-group><article-title>Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis</article-title><source>Cancer Immunol Immunother</source><volume>60</volume><fpage>187</fpage><lpage>195</lpage><year>2011</year></element-citation></ref>
<ref id="b89-ol-05-04-1101"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arakawa</surname><given-names>H</given-names></name></person-group><article-title>Netrin-1 and its receptors in tumorigenesis</article-title><source>Nat Rev Cancer</source><volume>4</volume><fpage>978</fpage><lpage>987</lpage><year>2004</year></element-citation></ref>
<ref id="b90-ol-05-04-1101"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalariti</surname><given-names>N</given-names></name><name><surname>Pissimissis</surname><given-names>N</given-names></name><name><surname>Koutsilieris</surname><given-names>M</given-names></name></person-group><article-title>The glutamatergic system outside the CNS and in cancer biology</article-title><source>Expert Opin Investig Drugs</source><volume>14</volume><fpage>1487</fpage><lpage>1496</lpage><year>2005</year></element-citation></ref>
<ref id="b91-ol-05-04-1101"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Maemura</surname><given-names>K</given-names></name><name><surname>Oki</surname><given-names>K</given-names></name><name><surname>Shiraishi</surname><given-names>N</given-names></name><name><surname>Shibayama</surname><given-names>Y</given-names></name><name><surname>Katsu</surname><given-names>K</given-names></name></person-group><article-title>Gamma-aminobutyric acid (GABA) and cell proliferation: focus on cancer cells</article-title><source>Histol Histopathol</source><volume>21</volume><fpage>1135</fpage><lpage>1141</lpage><year>2006</year></element-citation></ref>
<ref id="b92-ol-05-04-1101"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>HJ</given-names></name><name><surname>Yoo</surname><given-names>BC</given-names></name><name><surname>Lim</surname><given-names>SB</given-names></name><name><surname>Jeong</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>WH</given-names></name><name><surname>Park</surname><given-names>JG</given-names></name></person-group><article-title>Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance</article-title><source>Clin Cancer Res</source><volume>11</volume><fpage>3288</fpage><lpage>3295</lpage><year>2005</year></element-citation></ref>
<ref id="b93-ol-05-04-1101"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>SA</given-names></name><name><surname>Han</surname><given-names>IH</given-names></name><name><surname>Yoo</surname><given-names>BC</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>JY</given-names></name><name><surname>Cha</surname><given-names>IH</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Choi</surname><given-names>SW</given-names></name></person-group><article-title>Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma</article-title><source>Oncol Rep</source><volume>17</volume><fpage>81</fpage><lpage>87</lpage><year>2007</year></element-citation></ref>
<ref id="b94-ol-05-04-1101"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palma</surname><given-names>C</given-names></name></person-group><article-title>Tachykinins and their receptors in human malignancies</article-title><source>Curr Drug Targets</source><volume>7</volume><fpage>1043</fpage><lpage>1052</lpage><year>2006</year></element-citation></ref>
<ref id="b95-ol-05-04-1101"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruscica</surname><given-names>M</given-names></name><name><surname>Dozio</surname><given-names>E</given-names></name><name><surname>Motta</surname><given-names>M</given-names></name><name><surname>Magni</surname><given-names>P</given-names></name></person-group><article-title>Relevance of the neuropeptide Y system in the biology of cancer progression</article-title><source>Curr Top Med Chem</source><volume>7</volume><fpage>1682</fpage><lpage>1691</lpage><year>2007</year></element-citation></ref>
<ref id="b96-ol-05-04-1101"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatikhine</surname><given-names>VA</given-names></name><name><surname>Delpech</surname><given-names>B</given-names></name><name><surname>Duval</surname><given-names>C</given-names></name><name><surname>Chauzy</surname><given-names>C</given-names></name><name><surname>D&#x00027;Aniou</surname><given-names>J</given-names></name><name><surname>Chevrier</surname><given-names>A</given-names></name></person-group><article-title>Expression of beta-endorphin in human breast cancer and adenofibromas</article-title><source>Ann NY Acad Sci</source><volume>680</volume><fpage>473</fpage><lpage>475</lpage><year>1993</year></element-citation></ref>
<ref id="b97-ol-05-04-1101"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>DK</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Murugan</surname><given-names>S</given-names></name><name><surname>Dokur</surname><given-names>M</given-names></name><name><surname>Boyadjieva</surname><given-names>NI</given-names></name><name><surname>Ortiguela</surname><given-names>M</given-names></name><name><surname>Reuhl</surname><given-names>KR</given-names></name><name><surname>Mojtehedzadeh</surname><given-names>S</given-names></name></person-group><article-title>Transplantation of beta-endorphin neurons into the hypothalamus promotes immune function and restricts the growth and metastasis of mammary carcinoma</article-title><source>Cancer Res</source><volume>71</volume><fpage>6282</fpage><lpage>6291</lpage><year>2011</year></element-citation></ref>
<ref id="b98-ol-05-04-1101"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancino</surname><given-names>M</given-names></name><name><surname>Ametller</surname><given-names>E</given-names></name><name><surname>Gascon</surname><given-names>P</given-names></name><name><surname>Almendro</surname><given-names>V</given-names></name></person-group><article-title>The neuronal influence on tumor progression</article-title><source>Biochim Biophys Acta</source><volume>1816</volume><fpage>105</fpage><lpage>118</lpage><year>2011</year></element-citation></ref>
<ref id="b99-ol-05-04-1101"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDougall</surname><given-names>JR</given-names></name><name><surname>Matrisian</surname><given-names>LM</given-names></name></person-group><article-title>Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis</article-title><source>Cancer Metastasis Rev</source><volume>14</volume><fpage>351</fpage><lpage>362</lpage><year>1995</year></element-citation></ref>
<ref id="b100-ol-05-04-1101"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deryugina</surname><given-names>EI</given-names></name><name><surname>Quigley</surname><given-names>JP</given-names></name></person-group><article-title>Matrix metalloproteinases and tumor metastasis</article-title><source>Cancer Metastasis Rev</source><volume>25</volume><fpage>9</fpage><lpage>34</lpage><year>2006</year></element-citation></ref>
<ref id="b101-ol-05-04-1101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Yamaura</surname><given-names>T</given-names></name><name><surname>Murakami</surname><given-names>K</given-names></name><name><surname>Ogasawara</surname><given-names>M</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Murata</surname><given-names>J</given-names></name><name><surname>Saiki</surname><given-names>I</given-names></name></person-group><article-title>Involvement of TNF-alpha in enhancement of invasion and metastasis of colon 26-L5 carcinoma cells in mice by social isolation stress</article-title><source>Oncol Res</source><volume>11</volume><fpage>461</fpage><lpage>469</lpage><year>1999</year></element-citation></ref>
<ref id="b102-ol-05-04-1101"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>EV</given-names></name><name><surname>Bane</surname><given-names>CM</given-names></name><name><surname>MacCallum</surname><given-names>RC</given-names></name><name><surname>Kiecolt-Glaser</surname><given-names>JK</given-names></name><name><surname>Malarkey</surname><given-names>WB</given-names></name><name><surname>Glaser</surname><given-names>R</given-names></name></person-group><article-title>Stress-related modulation of matrix metalloproteinase expression</article-title><source>J Neuroimmunol</source><volume>133</volume><fpage>144</fpage><lpage>150</lpage><year>2002</year></element-citation></ref>
<ref id="b103-ol-05-04-1101"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Xiong</surname><given-names>S</given-names></name><name><surname>Klos</surname><given-names>K</given-names></name><name><surname>Nguyen</surname><given-names>N</given-names></name><name><surname>Grijalva</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name></person-group><article-title>Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells</article-title><source>Oncogene</source><volume>20</volume><fpage>8066</fpage><lpage>8074</lpage><year>2001</year></element-citation></ref>
<ref id="b104-ol-05-04-1101"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Eibl</surname><given-names>G</given-names></name><name><surname>Guha</surname><given-names>S</given-names></name><name><surname>Duffy</surname><given-names>JP</given-names></name><name><surname>Reber</surname><given-names>HA</given-names></name><name><surname>Hines</surname><given-names>OJ</given-names></name></person-group><article-title>Nerve growth factor stimulates MMP-2 expression and activity and increases invasion by human pancreatic cancer cells</article-title><source>Clin Exp Metastasis</source><volume>21</volume><fpage>285</fpage><lpage>292</lpage><year>2004</year></element-citation></ref>
<ref id="b105-ol-05-04-1101"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Eibl</surname><given-names>G</given-names></name><name><surname>Duffy</surname><given-names>JP</given-names></name><name><surname>Reber</surname><given-names>HA</given-names></name><name><surname>Hines</surname><given-names>OJ</given-names></name></person-group><article-title>Glial cell-derived neurotrophic factor upregulates the expression and activation of matrix metalloproteinase-9 in human pancreatic cancer</article-title><source>Surgery</source><volume>134</volume><fpage>293</fpage><lpage>299</lpage><year>2003</year></element-citation></ref>
<ref id="b106-ol-05-04-1101"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menter</surname><given-names>DG</given-names></name><name><surname>Herrmann</surname><given-names>JL</given-names></name><name><surname>Nicolson</surname><given-names>GL</given-names></name></person-group><article-title>The role of trophic factors and autocrine/paracrine growth factors in brain metastasis</article-title><source>Clin and Exp Metastasis</source><volume>13</volume><fpage>67</fpage><lpage>88</lpage><year>1995</year></element-citation></ref>
<ref id="b107-ol-05-04-1101"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>EV</given-names></name><name><surname>Sood</surname><given-names>AK</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Eubank</surname><given-names>TD</given-names></name><name><surname>Marsh</surname><given-names>CB</given-names></name><name><surname>Jewell</surname><given-names>S</given-names></name><name><surname>Flavahan</surname><given-names>NA</given-names></name><name><surname>Morrison</surname><given-names>C</given-names></name><name><surname>Yeh</surname><given-names>PE</given-names></name><name><surname>Lemeshow</surname><given-names>S</given-names></name><name><surname>Glaser</surname><given-names>R</given-names></name></person-group><article-title>Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells</article-title><source>Cancer Res</source><volume>66</volume><fpage>10357</fpage><lpage>10364</lpage><year>2006</year></element-citation></ref>
<ref id="b108-ol-05-04-1101"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azuma</surname><given-names>H</given-names></name><name><surname>Inamoto</surname><given-names>T</given-names></name><name><surname>Sakamoto</surname><given-names>T</given-names></name><name><surname>Kiyama</surname><given-names>S</given-names></name><name><surname>Ubai</surname><given-names>T</given-names></name><name><surname>Shinohara</surname><given-names>Y</given-names></name><name><surname>Maemura</surname><given-names>K</given-names></name><name><surname>Tsuji</surname><given-names>M</given-names></name><name><surname>Segawa</surname><given-names>N</given-names></name><name><surname>Masuda</surname><given-names>H</given-names></name><name><surname>Takahara</surname><given-names>K</given-names></name><name><surname>Katsuoka</surname><given-names>Y</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name></person-group><article-title>Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism</article-title><source>Cancer Res</source><volume>63</volume><fpage>8090</fpage><lpage>8096</lpage><year>2003</year></element-citation></ref>
<ref id="b109-ol-05-04-1101"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>CD</given-names></name><name><surname>Anyiwe</surname><given-names>K</given-names></name><name><surname>Schimmer</surname><given-names>AD</given-names></name></person-group><article-title>Anoikis resistance and tumor metastasis</article-title><source>Cancer Lett</source><volume>272</volume><fpage>177</fpage><lpage>185</lpage><year>2008</year></element-citation></ref>
<ref id="b110-ol-05-04-1101"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douma</surname><given-names>S</given-names></name><name><surname>Van Laar</surname><given-names>T</given-names></name><name><surname>Zevenhoven</surname><given-names>J</given-names></name><name><surname>Meuwissen</surname><given-names>R</given-names></name><name><surname>Van Garderen</surname><given-names>E</given-names></name><name><surname>Peeper</surname><given-names>DS</given-names></name></person-group><article-title>Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB</article-title><source>Nature</source><volume>430</volume><fpage>1034</fpage><lpage>1039</lpage><year>2004</year></element-citation></ref>
<ref id="b111-ol-05-04-1101"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geiger</surname><given-names>TR</given-names></name><name><surname>Peeper</surname><given-names>DS</given-names></name></person-group><article-title>The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective</article-title><source>Cancer Res</source><volume>65</volume><fpage>7033</fpage><lpage>7036</lpage><year>2005</year></element-citation></ref>
<ref id="b112-ol-05-04-1101"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geiger</surname><given-names>TR</given-names></name><name><surname>Peeper</surname><given-names>DS</given-names></name></person-group><article-title>Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis</article-title><source>Cancer Res</source><volume>67</volume><fpage>6221</fpage><lpage>6229</lpage><year>2007</year></element-citation></ref>
<ref id="b113-ol-05-04-1101"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strizzi</surname><given-names>L</given-names></name><name><surname>Bianco</surname><given-names>C</given-names></name><name><surname>Raafat</surname><given-names>A</given-names></name><name><surname>Abdallah</surname><given-names>W</given-names></name><name><surname>Chang</surname><given-names>C</given-names></name><name><surname>Raafat</surname><given-names>D</given-names></name><name><surname>Hirota</surname><given-names>M</given-names></name><name><surname>Hamada</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Normanno</surname><given-names>N</given-names></name><name><surname>Callahan</surname><given-names>R</given-names></name><name><surname>Hinck</surname><given-names>L</given-names></name><name><surname>Salomon</surname><given-names>D</given-names></name></person-group><article-title>Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo</article-title><source>J Cell Sci</source><volume>118</volume><fpage>4633</fpage><lpage>4643</lpage><year>2005</year></element-citation></ref>
<ref id="b114-ol-05-04-1101"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>C</given-names></name><name><surname>Ambartsumian</surname><given-names>N</given-names></name><name><surname>Gilestro</surname><given-names>G</given-names></name><name><surname>Thomsen</surname><given-names>B</given-names></name><name><surname>Comoglio</surname><given-names>P</given-names></name><name><surname>Tamagnone</surname><given-names>L</given-names></name><name><surname>Guldberg</surname><given-names>P</given-names></name><name><surname>Lukanidin</surname><given-names>E</given-names></name></person-group><article-title>Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis</article-title><source>Cancer Res</source><volume>65</volume><fpage>6167</fpage><lpage>6177</lpage><year>2005</year></element-citation></ref>
<ref id="b115-ol-05-04-1101"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruger</surname><given-names>RP</given-names></name><name><surname>Aurandt</surname><given-names>J</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name></person-group><article-title>Semaphorins command cells to move</article-title><source>Nat Rev Mol Cell Biol</source><volume>6</volume><fpage>789</fpage><lpage>800</lpage><year>2005</year></element-citation></ref>
<ref id="b116-ol-05-04-1101"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HK</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>TT</given-names></name><name><surname>Swisher</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Elmets</surname><given-names>CA</given-names></name><name><surname>Athar</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>XC</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name></person-group><article-title>Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma</article-title><source>Neoplasia</source><volume>10</volume><fpage>1411</fpage><lpage>1420</lpage><year>2008</year></element-citation></ref>
<ref id="b117-ol-05-04-1101"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casazza</surname><given-names>A</given-names></name><name><surname>Finisguerra</surname><given-names>V</given-names></name><name><surname>Capparuccia</surname><given-names>L</given-names></name><name><surname>Camperi</surname><given-names>A</given-names></name><name><surname>Swiercz</surname><given-names>JM</given-names></name><name><surname>Rizzolio</surname><given-names>S</given-names></name><name><surname>Rolny</surname><given-names>C</given-names></name><name><surname>Christensen</surname><given-names>C</given-names></name><name><surname>Bertotti</surname><given-names>A</given-names></name><name><surname>Sarotto</surname><given-names>I</given-names></name><name><surname>Risio</surname><given-names>M</given-names></name><name><surname>Trusolino</surname><given-names>L</given-names></name><name><surname>Weitz</surname><given-names>J</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Mazzone</surname><given-names>M</given-names></name><name><surname>Comoglio</surname><given-names>PM</given-names></name><name><surname>Tamagnone</surname><given-names>L</given-names></name></person-group><article-title>Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and meta-static spreading in mice</article-title><source>J Clin Invest</source><volume>120</volume><fpage>2684</fpage><lpage>2698</lpage><year>2010</year></element-citation></ref>
<ref id="b118-ol-05-04-1101"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Entschladen</surname><given-names>F</given-names></name><name><surname>Lang</surname><given-names>K</given-names></name><name><surname>Drell</surname><given-names>TL</given-names></name><name><surname>Joseph</surname><given-names>J</given-names></name><name><surname>Zaenker</surname><given-names>KS</given-names></name></person-group><article-title>Neurotransmitters are regulators for the migration of tumor cells and leukocytes</article-title><source>Cancer Immunol Immunother</source><volume>51</volume><fpage>467</fpage><lpage>482</lpage><year>2002</year></element-citation></ref>
<ref id="b119-ol-05-04-1101"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masur</surname><given-names>K</given-names></name><name><surname>Niggemann</surname><given-names>B</given-names></name><name><surname>Zanker</surname><given-names>KS</given-names></name><name><surname>Entschladen</surname><given-names>F</given-names></name></person-group><article-title>Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers</article-title><source>Cancer Res</source><volume>61</volume><fpage>2866</fpage><lpage>2869</lpage><year>2001</year></element-citation></ref>
<ref id="b120-ol-05-04-1101"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drell</surname><given-names>TT</given-names></name><name><surname>Joseph</surname><given-names>J</given-names></name><name><surname>Lang</surname><given-names>K</given-names></name><name><surname>Niggemann</surname><given-names>B</given-names></name><name><surname>Zaenker</surname><given-names>KS</given-names></name><name><surname>Entschladen</surname><given-names>F</given-names></name></person-group><article-title>Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells</article-title><source>Breast Cancer Res Treat</source><volume>80</volume><fpage>63</fpage><lpage>70</lpage><year>2003</year></element-citation></ref>
<ref id="b121-ol-05-04-1101"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joseph</surname><given-names>J</given-names></name><name><surname>Niggemann</surname><given-names>B</given-names></name><name><surname>Zaenker</surname><given-names>KS</given-names></name><name><surname>Entschladen</surname><given-names>F</given-names></name></person-group><article-title>The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cells</article-title><source>Cancer Res</source><volume>62</volume><fpage>6467</fpage><lpage>6469</lpage><year>2002</year></element-citation></ref>
<ref id="b122-ol-05-04-1101"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Maemura</surname><given-names>K</given-names></name><name><surname>Kanbara</surname><given-names>K</given-names></name><name><surname>Tamayama</surname><given-names>T</given-names></name><name><surname>Hayasaki</surname><given-names>H</given-names></name></person-group><article-title>GABA and GABA receptors in the central nervous system and other organs</article-title><source>Int Rev Cytol</source><volume>213</volume><fpage>1</fpage><lpage>47</lpage><year>2002</year></element-citation></ref>
<ref id="b123-ol-05-04-1101"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>RJ</given-names></name><name><surname>Rostene</surname><given-names>W</given-names></name><name><surname>Apartis</surname><given-names>E</given-names></name><name><surname>Banisadr</surname><given-names>G</given-names></name><name><surname>Biber</surname><given-names>K</given-names></name><name><surname>Milligan</surname><given-names>ED</given-names></name><name><surname>White</surname><given-names>FA</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>Chemokine action in the nervous system</article-title><source>J Neurosci</source><volume>28</volume><fpage>11792</fpage><lpage>11795</lpage><year>2008</year></element-citation></ref>
<ref id="b124-ol-05-04-1101"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Oppenheim</surname><given-names>JJ</given-names></name></person-group><article-title>Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems</article-title><source>J Leukoc Biol</source><volume>78</volume><fpage>1210</fpage><lpage>1214</lpage><year>2005</year></element-citation></ref>
<ref id="b125-ol-05-04-1101"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>A</given-names></name><name><surname>Homey</surname><given-names>B</given-names></name><name><surname>Soto</surname><given-names>H</given-names></name><name><surname>Ge</surname><given-names>N</given-names></name><name><surname>Catron</surname><given-names>D</given-names></name><name><surname>Buchanan</surname><given-names>ME</given-names></name><name><surname>McClanahan</surname><given-names>T</given-names></name><name><surname>Murphy</surname><given-names>E</given-names></name><name><surname>Yuan</surname><given-names>W</given-names></name><name><surname>Wagner</surname><given-names>SN</given-names></name><name><surname>Barrera</surname><given-names>JL</given-names></name><name><surname>Mohar</surname><given-names>A</given-names></name><name><surname>Verastegui</surname><given-names>E</given-names></name><name><surname>Zlotnik</surname><given-names>A</given-names></name></person-group><article-title>Involvement of chemokine receptors in breast cancer metastasis</article-title><source>Nature</source><volume>410</volume><fpage>50</fpage><lpage>56</lpage><year>2001</year></element-citation></ref>
<ref id="b126-ol-05-04-1101"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balkwill</surname><given-names>F</given-names></name></person-group><article-title>Cancer and the chemokine network</article-title><source>Nat Rev Cancer</source><volume>4</volume><fpage>540</fpage><lpage>550</lpage><year>2004</year></element-citation></ref>
<ref id="b127-ol-05-04-1101"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Sadanandam</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>RK</given-names></name></person-group><article-title>Chemokines in tumor angiogenesis and metastasis</article-title><source>Cancer Metastasis Rev</source><volume>26</volume><fpage>453</fpage><lpage>467</lpage><year>2007</year></element-citation></ref>
<ref id="b128-ol-05-04-1101"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>L</given-names></name></person-group><article-title>Cancer cell traffic from the lungs to the liver: an example of metastatic inefficiency</article-title><source>Int J Cancer</source><volume>25</volume><fpage>385</fpage><lpage>392</lpage><year>1980</year></element-citation></ref>
<ref id="b129-ol-05-04-1101"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>L</given-names></name></person-group><article-title>Deformation-driven, lethal damage to cancer cells. Its contribution to metastatic inefficiency</article-title><source>Cell Biophys</source><volume>18</volume><fpage>73</fpage><lpage>79</lpage><year>1991</year></element-citation></ref>
<ref id="b130-ol-05-04-1101"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacac</surname><given-names>M</given-names></name><name><surname>Stamenkovic</surname><given-names>I</given-names></name></person-group><article-title>Metastatic cancer cell</article-title><source>Annu Rev Pathol</source><volume>3</volume><fpage>221</fpage><lpage>247</lpage><year>2008</year></element-citation></ref>
<ref id="b131-ol-05-04-1101"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brain</surname><given-names>SD</given-names></name></person-group><article-title>Sensory neuropeptides: their role in inflammation and wound healing</article-title><source>Immunopharmacology</source><volume>37</volume><fpage>133</fpage><lpage>152</lpage><year>1997</year></element-citation></ref>
<ref id="b132-ol-05-04-1101"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishihara</surname><given-names>K</given-names></name><name><surname>Kamata</surname><given-names>M</given-names></name><name><surname>Hayashi</surname><given-names>I</given-names></name><name><surname>Yamashina</surname><given-names>S</given-names></name><name><surname>Majima</surname><given-names>M</given-names></name></person-group><article-title>Roles of bradykinin in vascular permeability and angiogenesis in solid tumor</article-title><source>Int Immunopharmacol</source><volume>2</volume><fpage>499</fpage><lpage>509</lpage><year>2002</year></element-citation></ref>
<ref id="b133-ol-05-04-1101"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x00027;Connor</surname><given-names>TM</given-names></name><name><surname>O&#x00027;Connell</surname><given-names>J</given-names></name><name><surname>O&#x00027;Brien</surname><given-names>DI</given-names></name><name><surname>Goode</surname><given-names>T</given-names></name><name><surname>Bredin</surname><given-names>CP</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name></person-group><article-title>The role of substance P in inflammatory disease</article-title><source>J Cell Physiol</source><volume>201</volume><fpage>167</fpage><lpage>180</lpage><year>2004</year></element-citation></ref>
<ref id="b134-ol-05-04-1101"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchesi</surname><given-names>F</given-names></name><name><surname>Piemonti</surname><given-names>L</given-names></name><name><surname>Mantovani</surname><given-names>A</given-names></name><name><surname>Allavena</surname><given-names>P</given-names></name></person-group><article-title>Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis</article-title><source>Cytokine Growth Factor Rev</source><volume>21</volume><fpage>77</fpage><lpage>82</lpage><year>2010</year></element-citation></ref>
<ref id="b135-ol-05-04-1101"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jhawer</surname><given-names>M</given-names></name><name><surname>Coit</surname><given-names>D</given-names></name><name><surname>Brennan</surname><given-names>M</given-names></name><name><surname>Qin</surname><given-names>LX</given-names></name><name><surname>Gonen</surname><given-names>M</given-names></name><name><surname>Klimstra</surname><given-names>D</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Kelsen</surname><given-names>DP</given-names></name><name><surname>Shah</surname><given-names>MA</given-names></name></person-group><article-title>Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation</article-title><source>Am J Clin Oncol</source><volume>32</volume><fpage>356</fpage><lpage>362</lpage><year>2009</year></element-citation></ref>
<ref id="b136-ol-05-04-1101"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilici</surname><given-names>A</given-names></name><name><surname>Seker</surname><given-names>M</given-names></name><name><surname>Ustaalioglu</surname><given-names>BB</given-names></name><name><surname>Kefeli</surname><given-names>U</given-names></name><name><surname>Yildirim</surname><given-names>E</given-names></name><name><surname>Yavuzer</surname><given-names>D</given-names></name><name><surname>Aydin</surname><given-names>FM</given-names></name><name><surname>Salepci</surname><given-names>T</given-names></name><name><surname>Oncel</surname><given-names>M</given-names></name><name><surname>Gumus</surname><given-names>M</given-names></name></person-group><article-title>Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection</article-title><source>Ann Surg Oncol</source><volume>17</volume><fpage>2037</fpage><lpage>2044</lpage><year>2010</year></element-citation></ref>
<ref id="b137-ol-05-04-1101"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceyhan</surname><given-names>GO</given-names></name><name><surname>Liebl</surname><given-names>F</given-names></name><name><surname>Maak</surname><given-names>M</given-names></name><name><surname>Schuster</surname><given-names>T</given-names></name><name><surname>Becker</surname><given-names>K</given-names></name><name><surname>Langer</surname><given-names>R</given-names></name><name><surname>Demir</surname><given-names>IE</given-names></name><name><surname>Hartel</surname><given-names>M</given-names></name><name><surname>Friess</surname><given-names>H</given-names></name><name><surname>Rosenberg</surname><given-names>R</given-names></name></person-group><article-title>The severity of neural invasion is a crucial prognostic factor in rectal cancer independent of neoadjuvant radiochemotherapy</article-title><source>Ann Surg</source><volume>252</volume><fpage>797</fpage><lpage>804</lpage><year>2010</year></element-citation></ref>
<ref id="b138-ol-05-04-1101"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binmadi</surname><given-names>NO</given-names></name><name><surname>Basile</surname><given-names>JR</given-names></name></person-group><article-title>Perineural invasion in oral squamous cell carcinoma: a discussion of significance and review of the literature</article-title><source>Oral Oncol</source><volume>47</volume><fpage>1005</fpage><lpage>1010</lpage><year>2011</year></element-citation></ref>
<ref id="b139-ol-05-04-1101"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>SK</given-names></name><name><surname>Li</surname><given-names>WY</given-names></name><name><surname>Chu</surname><given-names>PY</given-names></name><name><surname>Chang</surname><given-names>SY</given-names></name><name><surname>Tsai</surname><given-names>TL</given-names></name><name><surname>Wang</surname><given-names>YF</given-names></name><name><surname>Huang</surname><given-names>JL</given-names></name></person-group><article-title>Risks and clinical implications of perineural invasion in T1-2 oral tongue squamous cell carcinoma</article-title><source>Head Neck</source><volume>34</volume><fpage>994</fpage><lpage>1001</lpage><year>2011</year></element-citation></ref>
<ref id="b140-ol-05-04-1101"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>ME</given-names></name><name><surname>Palla</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Elashoff</surname><given-names>DA</given-names></name><name><surname>Abemayor</surname><given-names>E</given-names></name><name><surname>St John</surname><given-names>JM</given-names></name><name><surname>Lai</surname><given-names>CK</given-names></name></person-group><article-title>A novel classification system for perineural invasion in noncutaneous head and neck squamous cell carcinoma: histologic subcategories and patient outcomes</article-title><source>Am J Otolaryngol</source><volume>33</volume><fpage>212</fpage><lpage>215</lpage><year>2012</year></element-citation></ref>
<ref id="b141-ol-05-04-1101"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hibi</surname><given-names>T</given-names></name><name><surname>Mori</surname><given-names>T</given-names></name><name><surname>Fukuma</surname><given-names>M</given-names></name><name><surname>Yamazaki</surname><given-names>K</given-names></name><name><surname>Hashiguchi</surname><given-names>A</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Tanabe</surname><given-names>M</given-names></name><name><surname>Aiura</surname><given-names>K</given-names></name><name><surname>Kawakami</surname><given-names>T</given-names></name><name><surname>Ogiwara</surname><given-names>A</given-names></name><name><surname>Kosuge</surname><given-names>T</given-names></name><name><surname>Kitajima</surname><given-names>M</given-names></name><name><surname>Kitagawa</surname><given-names>Y</given-names></name><name><surname>Sakamoto</surname><given-names>M</given-names></name></person-group><article-title>Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer</article-title><source>Clin Cancer Res</source><volume>15</volume><fpage>2864</fpage><lpage>2871</lpage><year>2009</year></element-citation></ref>
<ref id="b142-ol-05-04-1101"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karak</surname><given-names>SG</given-names></name><name><surname>Quatrano</surname><given-names>N</given-names></name><name><surname>Buckley</surname><given-names>J</given-names></name><name><surname>Ricci</surname><given-names>AJ</given-names></name></person-group><article-title>Prevalence and significance of perineural invasion in invasive breast carcinoma</article-title><source>Conn Med</source><volume>74</volume><fpage>17</fpage><lpage>21</lpage><year>2010</year></element-citation></ref>
<ref id="b143-ol-05-04-1101"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meinel</surname><given-names>A</given-names></name><name><surname>Fischer</surname><given-names>U</given-names></name><name><surname>Bilek</surname><given-names>K</given-names></name><name><surname>Hentschel</surname><given-names>B</given-names></name><name><surname>Horn</surname><given-names>LC</given-names></name></person-group><article-title>Morphological parameters associated with perineural invasion (PNI) in carcinoma of the cervix uteri</article-title><source>Int J Surg Pathol</source><volume>19</volume><fpage>159</fpage><lpage>163</lpage><year>2011</year></element-citation></ref>
<ref id="b144-ol-05-04-1101"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bixby</surname><given-names>JL</given-names></name><name><surname>Harris</surname><given-names>WA</given-names></name></person-group><article-title>Molecular mechanisms of axon growth and guidance</article-title><source>Annu Rev Cell Biol</source><volume>7</volume><fpage>117</fpage><lpage>159</lpage><year>1991</year></element-citation></ref>
<ref id="b145-ol-05-04-1101"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>JL</given-names></name></person-group><article-title>How does an axon grow?</article-title><source>Genes Dev</source><volume>17</volume><fpage>941</fpage><lpage>958</lpage><year>2003</year></element-citation></ref>
<ref id="b146-ol-05-04-1101"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasterkamp</surname><given-names>RJ</given-names></name><name><surname>Peschon</surname><given-names>JJ</given-names></name><name><surname>Spriggs</surname><given-names>MK</given-names></name><name><surname>Kolodkin</surname><given-names>AL</given-names></name></person-group><article-title>Semaphorin 7A promotes axon outgrowth through integrins and MAPKs</article-title><source>Nature</source><volume>424</volume><fpage>398</fpage><lpage>405</lpage><year>2003</year></element-citation></ref>
<ref id="b147-ol-05-04-1101"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chilton</surname><given-names>JK</given-names></name></person-group><article-title>Molecular mechanisms of axon guidance</article-title><source>Dev Biol</source><volume>292</volume><fpage>13</fpage><lpage>24</lpage><year>2006</year></element-citation></ref>
<ref id="b148-ol-05-04-1101"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winckler</surname><given-names>B</given-names></name></person-group><article-title>BDNF instructs the kinase LKB1 to grow an axon</article-title><source>Cell</source><volume>129</volume><fpage>459</fpage><lpage>460</lpage><year>2007</year></element-citation></ref>
<ref id="b149-ol-05-04-1101"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artigiani</surname><given-names>S</given-names></name><name><surname>Comoglio</surname><given-names>PM</given-names></name><name><surname>Tamagnone</surname><given-names>L</given-names></name></person-group><article-title>Plexins, semaphorins, and scatter factor receptors: a common root for cell guidance signals?</article-title><source>Iubmb Life</source><volume>48</volume><fpage>477</fpage><lpage>482</lpage><year>1999</year></element-citation></ref>
<ref id="b150-ol-05-04-1101"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwahashi</surname><given-names>N</given-names></name><name><surname>Nagasaka</surname><given-names>T</given-names></name><name><surname>Tezel</surname><given-names>G</given-names></name><name><surname>Iwashita</surname><given-names>T</given-names></name><name><surname>Asai</surname><given-names>N</given-names></name><name><surname>Murakumo</surname><given-names>Y</given-names></name><name><surname>Kiuchi</surname><given-names>K</given-names></name><name><surname>Sakata</surname><given-names>K</given-names></name><name><surname>Nimura</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name></person-group><article-title>Expression of glial cell line-derived neurotrophic factor correlates with perineural invasion of bile duct carcinoma</article-title><source>Cancer</source><volume>94</volume><fpage>167</fpage><lpage>174</lpage><year>2002</year></element-citation></ref>
<ref id="b151-ol-05-04-1101"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomaselli</surname><given-names>KJ</given-names></name><name><surname>Reichardt</surname><given-names>LF</given-names></name><name><surname>Bixby</surname><given-names>JL</given-names></name></person-group><article-title>Distinct molecular interactions mediate neuronal process outgrowth on nonneuronal cell surfaces and extracellular matrices</article-title><source>J Cell Biol</source><volume>103</volume><fpage>2659</fpage><lpage>2672</lpage><year>1986</year></element-citation></ref>
<ref id="b152-ol-05-04-1101"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folkman</surname><given-names>J</given-names></name></person-group><article-title>Role of angiogenesis in tumor growth and metastasis</article-title><source>Semin Oncol</source><volume>29</volume><fpage>15</fpage><lpage>18</lpage><year>2002</year></element-citation></ref>
<ref id="b153-ol-05-04-1101"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillen</surname><given-names>F</given-names></name><name><surname>Griffioen</surname><given-names>AW</given-names></name></person-group><article-title>Tumour vascularization: sprouting angiogenesis and beyond</article-title><source>Cancer Metastasis Rev</source><volume>26</volume><fpage>489</fpage><lpage>502</lpage><year>2007</year></element-citation></ref>
<ref id="b154-ol-05-04-1101"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weis</surname><given-names>SM</given-names></name><name><surname>Cheresh</surname><given-names>DA</given-names></name></person-group><article-title>Tumor angiogenesis: molecular pathways and therapeutic targets</article-title><source>Nat Med</source><volume>17</volume><fpage>1359</fpage><lpage>1370</lpage><year>2011</year></element-citation></ref>
<ref id="b155-ol-05-04-1101"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutgendorf</surname><given-names>SK</given-names></name><name><surname>Cole</surname><given-names>S</given-names></name><name><surname>Costanzo</surname><given-names>E</given-names></name><name><surname>Bradley</surname><given-names>S</given-names></name><name><surname>Coffin</surname><given-names>J</given-names></name><name><surname>Jabbari</surname><given-names>S</given-names></name><name><surname>Rainwater</surname><given-names>K</given-names></name><name><surname>Ritchie</surname><given-names>JM</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Sood</surname><given-names>AK</given-names></name></person-group><article-title>Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines</article-title><source>Clin Cancer Res</source><volume>9</volume><fpage>4514</fpage><lpage>4521</lpage><year>2003</year></element-citation></ref>
<ref id="b156-ol-05-04-1101"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thaker</surname><given-names>PH</given-names></name><name><surname>Han</surname><given-names>LY</given-names></name><name><surname>Kamat</surname><given-names>AA</given-names></name><name><surname>Arevalo</surname><given-names>JM</given-names></name><name><surname>Takahashi</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Jennings</surname><given-names>NB</given-names></name><name><surname>Armaiz-Pena</surname><given-names>G</given-names></name><name><surname>Bankson</surname><given-names>JA</given-names></name><name><surname>Ravoori</surname><given-names>M</given-names></name><name><surname>Merritt</surname><given-names>WM</given-names></name><name><surname>Lin</surname><given-names>YG</given-names></name><name><surname>Mangala</surname><given-names>LS</given-names></name><name><surname>Kim</surname><given-names>TJ</given-names></name><name><surname>Coleman</surname><given-names>RL</given-names></name><name><surname>Landen</surname><given-names>CN</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Felix</surname><given-names>E</given-names></name><name><surname>Sanguino</surname><given-names>AM</given-names></name><name><surname>Newman</surname><given-names>RA</given-names></name><name><surname>Lloyd</surname><given-names>M</given-names></name><name><surname>Gershenson</surname><given-names>DM</given-names></name><name><surname>Kundra</surname><given-names>V</given-names></name><name><surname>Lopez-Berestein</surname><given-names>G</given-names></name><name><surname>Lutgendorf</surname><given-names>SK</given-names></name><name><surname>Cole</surname><given-names>SW</given-names></name><name><surname>Sood</surname><given-names>AK</given-names></name></person-group><article-title>Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma</article-title><source>Nat Med</source><volume>12</volume><fpage>939</fpage><lpage>944</lpage><year>2006</year></element-citation></ref>
<ref id="b157-ol-05-04-1101"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tilan</surname><given-names>J</given-names></name><name><surname>Kitlinska</surname><given-names>J</given-names></name></person-group><article-title>Sympathetic neurotransmitters and tumor angiogenesis - link between stress and cancer progression</article-title><source>J Oncol</source><fpage>539706</fpage><year>2010</year></element-citation></ref>
<ref id="b158-ol-05-04-1101"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Jeong</surname><given-names>KJ</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>JW</given-names></name><name><surname>Choi</surname><given-names>WS</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>CG</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name></person-group><article-title>Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1&#x003B1; protein-dependent mechanism</article-title><source>Int J Cancer</source><volume>128</volume><fpage>2306</fpage><lpage>2316</lpage><year>2011</year></element-citation></ref>
<ref id="b159-ol-05-04-1101"><label>159</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakroborty</surname><given-names>D</given-names></name><name><surname>Sarkar</surname><given-names>C</given-names></name><name><surname>Basu</surname><given-names>B</given-names></name><name><surname>Dasgupta</surname><given-names>PS</given-names></name><name><surname>Basu</surname><given-names>S</given-names></name></person-group><article-title>Catecholamines regulate tumor angiogenesis</article-title><source>Cancer Res</source><volume>69</volume><fpage>3727</fpage><lpage>3730</lpage><year>2009</year></element-citation></ref>
<ref id="b160-ol-05-04-1101"><label>160</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakroborty</surname><given-names>D</given-names></name><name><surname>Sarkar</surname><given-names>C</given-names></name><name><surname>Mitra</surname><given-names>RB</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Dasgupta</surname><given-names>PS</given-names></name><name><surname>Basu</surname><given-names>S</given-names></name></person-group><article-title>Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis</article-title><source>Clin Cancer Res</source><volume>10</volume><fpage>4349</fpage><lpage>4356</lpage><year>2004</year></element-citation></ref>
<ref id="b161-ol-05-04-1101"><label>161</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basu</surname><given-names>S</given-names></name><name><surname>Nagy</surname><given-names>JA</given-names></name><name><surname>Pal</surname><given-names>S</given-names></name><name><surname>Vasile</surname><given-names>E</given-names></name><name><surname>Eckelhoefer</surname><given-names>IA</given-names></name><name><surname>Bliss</surname><given-names>VS</given-names></name><name><surname>Manseau</surname><given-names>EJ</given-names></name><name><surname>Dasgupta</surname><given-names>PS</given-names></name><name><surname>Dvorak</surname><given-names>HF</given-names></name><name><surname>Mukhopadhyay</surname><given-names>D</given-names></name></person-group><article-title>The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor</article-title><source>Nat Med</source><volume>7</volume><fpage>569</fpage><lpage>574</lpage><year>2001</year></element-citation></ref>
<ref id="b162-ol-05-04-1101"><label>162</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutgendorf</surname><given-names>SK</given-names></name><name><surname>DeGeest</surname><given-names>K</given-names></name><name><surname>Dahmoush</surname><given-names>L</given-names></name><name><surname>Farley</surname><given-names>D</given-names></name><name><surname>Penedo</surname><given-names>F</given-names></name><name><surname>Bender</surname><given-names>D</given-names></name><name><surname>Goodheart</surname><given-names>M</given-names></name><name><surname>Buekers</surname><given-names>TE</given-names></name><name><surname>Mendez</surname><given-names>L</given-names></name><name><surname>Krueger</surname><given-names>G</given-names></name><name><surname>Clevenger</surname><given-names>L</given-names></name><name><surname>Lubaroff</surname><given-names>DM</given-names></name><name><surname>Sood</surname><given-names>AK</given-names></name><name><surname>Cole</surname><given-names>SW</given-names></name></person-group><article-title>Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients</article-title><source>Brain Behav Immun</source><volume>25</volume><fpage>250</fpage><lpage>255</lpage><year>2011</year></element-citation></ref>
<ref id="b163-ol-05-04-1101"><label>163</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basile</surname><given-names>JR</given-names></name><name><surname>Castilho</surname><given-names>RM</given-names></name><name><surname>Williams</surname><given-names>VP</given-names></name><name><surname>Gutkind</surname><given-names>JS</given-names></name></person-group><article-title>Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis</article-title><source>Proc Natl Acad Sci USA</source><volume>103</volume><fpage>9017</fpage><lpage>9022</lpage><year>2006</year></element-citation></ref>
<ref id="b164-ol-05-04-1101"><label>164</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kigel</surname><given-names>B</given-names></name><name><surname>Rabinowicz</surname><given-names>N</given-names></name><name><surname>Varshavsky</surname><given-names>A</given-names></name><name><surname>Kessler</surname><given-names>O</given-names></name><name><surname>Neufeld</surname><given-names>G</given-names></name></person-group><article-title>Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling</article-title><source>Blood</source><volume>118</volume><fpage>4285</fpage><lpage>4296</lpage><year>2011</year></element-citation></ref>
<ref id="b165-ol-05-04-1101"><label>165</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casazza</surname><given-names>A</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Johansson</surname><given-names>I</given-names></name><name><surname>Capparuccia</surname><given-names>L</given-names></name><name><surname>Andersson</surname><given-names>F</given-names></name><name><surname>Giustacchini</surname><given-names>A</given-names></name><name><surname>Squadrito</surname><given-names>ML</given-names></name><name><surname>Venneri</surname><given-names>MA</given-names></name><name><surname>Mazzone</surname><given-names>M</given-names></name><name><surname>Larsson</surname><given-names>E</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>De Palma</surname><given-names>M</given-names></name><name><surname>Naldini</surname><given-names>L</given-names></name><name><surname>Tamagnone</surname><given-names>L</given-names></name><name><surname>Rolny</surname><given-names>C</given-names></name></person-group><article-title>Systemic and targeted delivery of semaphorin 3A inhibits tumor angiogenesis and progression in mouse tumor models</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>31</volume><fpage>741</fpage><lpage>749</lpage><year>2011</year></element-citation></ref>
<ref id="b166-ol-05-04-1101"><label>166</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakurai</surname><given-names>A</given-names></name><name><surname>Doci</surname><given-names>C</given-names></name><name><surname>Gutkind</surname><given-names>JS</given-names></name></person-group><article-title>Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer</article-title><source>Cell Res</source><volume>22</volume><fpage>23</fpage><lpage>32</lpage><year>2012</year></element-citation></ref>
<ref id="b167-ol-05-04-1101"><label>167</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toda</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Hosono</surname><given-names>K</given-names></name><name><surname>Hayashi</surname><given-names>I</given-names></name><name><surname>Hashiba</surname><given-names>S</given-names></name><name><surname>Onuma</surname><given-names>Y</given-names></name><name><surname>Amano</surname><given-names>H</given-names></name><name><surname>Kurihara</surname><given-names>Y</given-names></name><name><surname>Kurihara</surname><given-names>H</given-names></name><name><surname>Okamoto</surname><given-names>H</given-names></name><name><surname>Hoka</surname><given-names>S</given-names></name><name><surname>Majima</surname><given-names>M</given-names></name></person-group><article-title>Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide</article-title><source>Proc Natl Acad Sci USA</source><volume>105</volume><fpage>13550</fpage><lpage>13555</lpage><year>2008</year></element-citation></ref>
<ref id="b168-ol-05-04-1101"><label>168</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>EW</given-names></name><name><surname>Michalkiewicz</surname><given-names>M</given-names></name><name><surname>Kitlinska</surname><given-names>J</given-names></name><name><surname>Kalezic</surname><given-names>I</given-names></name><name><surname>Switalska</surname><given-names>H</given-names></name><name><surname>Yoo</surname><given-names>P</given-names></name><name><surname>Sangkharat</surname><given-names>A</given-names></name><name><surname>Ji</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Michalkiewicz</surname><given-names>T</given-names></name><name><surname>Ljubisavljevic</surname><given-names>M</given-names></name><name><surname>Johansson</surname><given-names>H</given-names></name><name><surname>Grant</surname><given-names>DS</given-names></name><name><surname>Zukowska</surname><given-names>Z</given-names></name></person-group><article-title>Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles</article-title><source>J Clin Invest</source><volume>111</volume><fpage>1853</fpage><lpage>1862</lpage><year>2003</year></element-citation></ref>
<ref id="b169-ol-05-04-1101"><label>169</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filipski</surname><given-names>E</given-names></name><name><surname>Levi</surname><given-names>F</given-names></name></person-group><article-title>Circadian disruption in experimental cancer processes</article-title><source>Integr Cancer Ther</source><volume>8</volume><fpage>298</fpage><lpage>302</lpage><year>2009</year></element-citation></ref>
<ref id="b170-ol-05-04-1101"><label>170</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodwin</surname><given-names>AM</given-names></name><name><surname>D&#x00027;Amore</surname><given-names>PA</given-names></name></person-group><article-title>Wnt signaling in the vasculature</article-title><source>Angiogenesis</source><volume>5</volume><fpage>1</fpage><lpage>9</lpage><year>2002</year></element-citation></ref>
<ref id="b171-ol-05-04-1101"><label>171</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masckauchan</surname><given-names>TN</given-names></name><name><surname>Kitajewski</surname><given-names>J</given-names></name></person-group><article-title>Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight</article-title><source>Physiology (Bethesda)</source><volume>21</volume><fpage>181</fpage><lpage>188</lpage><year>2006</year></element-citation></ref>
<ref id="b172-ol-05-04-1101"><label>172</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>RH</given-names></name><name><surname>Eichmann</surname><given-names>A</given-names></name></person-group><article-title>Axon guidance molecules in vascular patterning</article-title><source>Cold Spring Harb Perspect Biol</source><volume>2</volume><fpage>a1875</fpage><year>2010</year></element-citation></ref>
<ref id="b173-ol-05-04-1101"><label>173</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melani</surname><given-names>M</given-names></name><name><surname>Weinstein</surname><given-names>BM</given-names></name></person-group><article-title>Common factors regulating patterning of the nervous and vascular systems</article-title><source>Annu Rev Cell Dev Biol</source><volume>26</volume><fpage>639</fpage><lpage>665</lpage><year>2010</year></element-citation></ref>
<ref id="b174-ol-05-04-1101"><label>174</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name></person-group><article-title>Common mechanisms of nerve and blood vessel wiring</article-title><source>Nature</source><volume>436</volume><fpage>193</fpage><lpage>200</lpage><year>2005</year></element-citation></ref>
<ref id="b175-ol-05-04-1101"><label>175</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Entschladen</surname><given-names>F</given-names></name><name><surname>Palm</surname><given-names>D</given-names></name><name><surname>Drell</surname><given-names>TT</given-names></name><name><surname>Lang</surname><given-names>K</given-names></name><name><surname>Zaenker</surname><given-names>KS</given-names></name></person-group><article-title>Connecting a tumor to the environment</article-title><source>Curr Pharm Des</source><volume>13</volume><fpage>3440</fpage><lpage>3444</lpage><year>2007</year></element-citation></ref>
<ref id="b176-ol-05-04-1101"><label>176</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capparuccia</surname><given-names>L</given-names></name><name><surname>Tamagnone</surname><given-names>L</given-names></name></person-group><article-title>Semaphorin signaling in cancer cells and in cells of the tumor microenvironment - two sides of a coin</article-title><source>J Cell Sci</source><volume>122</volume><fpage>1723</fpage><lpage>1736</lpage><year>2009</year></element-citation></ref>
<ref id="b177-ol-05-04-1101"><label>177</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schirrmacher</surname><given-names>V</given-names></name><name><surname>Fogel</surname><given-names>M</given-names></name><name><surname>Russmann</surname><given-names>E</given-names></name><name><surname>Bosslet</surname><given-names>K</given-names></name><name><surname>Altevogt</surname><given-names>P</given-names></name><name><surname>Beck</surname><given-names>L</given-names></name></person-group><article-title>Antigenic variation in cancer metastasis: immune escape versus immune control</article-title><source>Cancer Metastasis Rev</source><volume>1</volume><fpage>241</fpage><lpage>274</lpage><year>1982</year></element-citation></ref>
<ref id="b178-ol-05-04-1101"><label>178</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Strasner</surname><given-names>A</given-names></name><name><surname>Grivennikov</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>JQ</given-names></name><name><surname>Hoffman</surname><given-names>RM</given-names></name><name><surname>Karin</surname><given-names>M</given-names></name></person-group><article-title>Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling</article-title><source>Nature</source><volume>470</volume><fpage>548</fpage><lpage>553</lpage><year>2011</year></element-citation></ref>
<ref id="b179-ol-05-04-1101"><label>179</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabin</surname><given-names>BS</given-names></name><name><surname>Cohen</surname><given-names>S</given-names></name><name><surname>Ganguli</surname><given-names>R</given-names></name><name><surname>Lysle</surname><given-names>DT</given-names></name><name><surname>Cunnick</surname><given-names>JE</given-names></name></person-group><article-title>Bidirectional interaction between the central nervous system and the immune system</article-title><source>Crit Rev Immunol</source><volume>9</volume><fpage>279</fpage><lpage>312</lpage><year>1989</year></element-citation></ref>
<ref id="b180-ol-05-04-1101"><label>180</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinman</surname><given-names>L</given-names></name></person-group><article-title>Connections between the immune system and the nervous system</article-title><source>Proc Natl Acad Sci USA</source><volume>90</volume><fpage>7912</fpage><lpage>7914</lpage><year>1993</year></element-citation></ref>
<ref id="b181-ol-05-04-1101"><label>181</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grivennikov</surname><given-names>SI</given-names></name><name><surname>Greten</surname><given-names>FR</given-names></name><name><surname>Karin</surname><given-names>M</given-names></name></person-group><article-title>Immunity, inflammation, and cancer</article-title><source>Cell</source><volume>140</volume><fpage>883</fpage><lpage>899</lpage><year>2010</year></element-citation></ref>
<ref id="b182-ol-05-04-1101"><label>182</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>WW</given-names></name><name><surname>Karin</surname><given-names>M</given-names></name></person-group><article-title>A cytokine-mediated link between innate immunity, inflammation, and cancer</article-title><source>J Clin Invest</source><volume>117</volume><fpage>1175</fpage><lpage>1183</lpage><year>2007</year></element-citation></ref>
<ref id="b183-ol-05-04-1101"><label>183</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karin</surname><given-names>M</given-names></name><name><surname>Greten</surname><given-names>FR</given-names></name></person-group><article-title>NF-kappaB: linking inflammation and immunity to cancer development and progression</article-title><source>Nat Rev Immunol</source><volume>5</volume><fpage>749</fpage><lpage>759</lpage><year>2005</year></element-citation></ref>
<ref id="b184-ol-05-04-1101"><label>184</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Eliyahu</surname><given-names>S</given-names></name><name><surname>Yirmiya</surname><given-names>R</given-names></name><name><surname>Liebeskind</surname><given-names>JC</given-names></name><name><surname>Taylor</surname><given-names>AN</given-names></name><name><surname>Gale</surname><given-names>RP</given-names></name></person-group><article-title>Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system</article-title><source>Brain Behav Immun</source><volume>5</volume><fpage>193</fpage><lpage>205</lpage><year>1991</year></element-citation></ref>
<ref id="b185-ol-05-04-1101"><label>185</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Eliyahu</surname><given-names>S</given-names></name><name><surname>Page</surname><given-names>GG</given-names></name><name><surname>Yirmiya</surname><given-names>R</given-names></name><name><surname>Shakhar</surname><given-names>G</given-names></name></person-group><article-title>Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity</article-title><source>Int J Cancer</source><volume>80</volume><fpage>880</fpage><lpage>888</lpage><year>1999</year></element-citation></ref>
<ref id="b186-ol-05-04-1101"><label>186</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>SM</given-names></name><name><surname>Herberman</surname><given-names>RB</given-names></name><name><surname>Lippman</surname><given-names>M</given-names></name><name><surname>D&#x00027;Angelo</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name></person-group><article-title>Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer</article-title><source>Behav Med</source><volume>17</volume><fpage>67</fpage><lpage>75</lpage><year>1991</year></element-citation></ref>
<ref id="b187-ol-05-04-1101"><label>187</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logan</surname><given-names>RW</given-names></name><name><surname>Sarkar</surname><given-names>DK</given-names></name></person-group><article-title>Circadian nature of immune function</article-title><source>Mol Cell Endocrinol</source><volume>349</volume><fpage>82</fpage><lpage>90</lpage><year>2012</year></element-citation></ref>
<ref id="b188-ol-05-04-1101"><label>188</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rana</surname><given-names>S</given-names></name><name><surname>Mahmood</surname><given-names>S</given-names></name></person-group><article-title>Circadian rhythm and its role in malignancy</article-title><source>J Circadian Rhythms</source><volume>8</volume><fpage>3</fpage><year>2010</year></element-citation></ref>
<ref id="b189-ol-05-04-1101"><label>189</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiecolt-Glaser</surname><given-names>JK</given-names></name><name><surname>Glaser</surname><given-names>R</given-names></name></person-group><article-title>Psychoneuroimmunology and cancer: fact or fiction?</article-title><source>Eur J Cancer</source><volume>35</volume><fpage>1603</fpage><lpage>1607</lpage><year>1999</year></element-citation></ref>
<ref id="b190-ol-05-04-1101"><label>190</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tracey</surname><given-names>KJ</given-names></name></person-group><article-title>The inflammatory reflex</article-title><source>Nature</source><volume>420</volume><fpage>853</fpage><lpage>859</lpage><year>2002</year></element-citation></ref>
<ref id="b191-ol-05-04-1101"><label>191</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libert</surname><given-names>C</given-names></name></person-group><article-title>Inflammation: A nervous connection</article-title><source>Nature</source><volume>421</volume><fpage>328</fpage><lpage>329</lpage><year>2003</year></element-citation></ref>
<ref id="b192-ol-05-04-1101"><label>192</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosas-Ballina</surname><given-names>M</given-names></name><name><surname>Tracey</surname><given-names>KJ</given-names></name></person-group><article-title>Cholinergic control of inflammation</article-title><source>J Intern Med</source><volume>265</volume><fpage>663</fpage><lpage>679</lpage><year>2009</year></element-citation></ref>
<ref id="b193-ol-05-04-1101"><label>193</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberger</surname><given-names>P</given-names></name><name><surname>Schwab</surname><given-names>JM</given-names></name><name><surname>Mirakaj</surname><given-names>V</given-names></name><name><surname>Masekowsky</surname><given-names>E</given-names></name><name><surname>Mager</surname><given-names>A</given-names></name><name><surname>Morote-Garcia</surname><given-names>JC</given-names></name><name><surname>Unertl</surname><given-names>K</given-names></name><name><surname>Eltzschig</surname><given-names>HK</given-names></name></person-group><article-title>Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia</article-title><source>Nat Immunol</source><volume>10</volume><fpage>195</fpage><lpage>202</lpage><year>2009</year></element-citation></ref>
<ref id="b194-ol-05-04-1101"><label>194</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tracey</surname><given-names>KJ</given-names></name></person-group><article-title>Reflex control of immunity</article-title><source>Nat Rev Immunol</source><volume>9</volume><fpage>418</fpage><lpage>428</lpage><year>2009</year></element-citation></ref>
<ref id="b195-ol-05-04-1101"><label>195</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Der Zanden</surname><given-names>EP</given-names></name><name><surname>Boeckxstaens</surname><given-names>GE</given-names></name><name><surname>de Jonge</surname><given-names>WJ</given-names></name></person-group><article-title>The vagus nerve as a modulator of intestinal inflammation</article-title><source>Neurogastroenterol Motil</source><volume>21</volume><fpage>6</fpage><lpage>17</lpage><year>2009</year></element-citation></ref>
<ref id="b196-ol-05-04-1101"><label>196</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>S</given-names></name><name><surname>Weigert</surname><given-names>A</given-names></name><name><surname>Brune</surname><given-names>B</given-names></name></person-group><article-title>Neuromediators in inflammation - a macrophage/nerve connection</article-title><source>Immunobiology</source><volume>215</volume><fpage>674</fpage><lpage>684</lpage><year>2010</year></element-citation></ref>
<ref id="b197-ol-05-04-1101"><label>197</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meregnani</surname><given-names>J</given-names></name><name><surname>Clarencon</surname><given-names>D</given-names></name><name><surname>Vivier</surname><given-names>M</given-names></name><name><surname>Peinnequin</surname><given-names>A</given-names></name><name><surname>Mouret</surname><given-names>C</given-names></name><name><surname>Sinniger</surname><given-names>V</given-names></name><name><surname>Picq</surname><given-names>C</given-names></name><name><surname>Job</surname><given-names>A</given-names></name><name><surname>Canini</surname><given-names>F</given-names></name><name><surname>Jacquier-Sarlin</surname><given-names>M</given-names></name><name><surname>Bonaz</surname><given-names>B</given-names></name></person-group><article-title>Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease</article-title><source>Auton Neurosci</source><volume>160</volume><fpage>82</fpage><lpage>89</lpage><year>2011</year></element-citation></ref>
<ref id="b198-ol-05-04-1101"><label>198</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pohanka</surname><given-names>M</given-names></name><name><surname>Snopkova</surname><given-names>S</given-names></name><name><surname>Havlickova</surname><given-names>K</given-names></name><name><surname>Bostik</surname><given-names>P</given-names></name><name><surname>Sinkorova</surname><given-names>Z</given-names></name><name><surname>Fusek</surname><given-names>J</given-names></name><name><surname>Kuca</surname><given-names>K</given-names></name><name><surname>Pikula</surname><given-names>J</given-names></name></person-group><article-title>Macrophage-assisted inflammation and pharmacological regulation of the cholinergic anti-inflammatory pathway</article-title><source>Curr Med Chem</source><volume>18</volume><fpage>539</fpage><lpage>551</lpage><year>2011</year></element-citation></ref>
<ref id="b199-ol-05-04-1101"><label>199</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerejeira</surname><given-names>J</given-names></name><name><surname>Nogueira</surname><given-names>V</given-names></name><name><surname>Luis</surname><given-names>P</given-names></name><name><surname>Vaz-Serra</surname><given-names>A</given-names></name><name><surname>Mukaetova-Ladinska</surname><given-names>EB</given-names></name></person-group><article-title>The cholinergic system and inflammation: common pathways in delirium pathophysiology</article-title><source>J Am Geriatr Soc</source><volume>60</volume><fpage>669</fpage><lpage>675</lpage><year>2012</year></element-citation></ref>
<ref id="b200-ol-05-04-1101"><label>200</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>CY</given-names></name><name><surname>Krzyzaniak</surname><given-names>M</given-names></name><name><surname>Coimbra</surname><given-names>R</given-names></name><name><surname>Chang</surname><given-names>DC</given-names></name></person-group><article-title>Vagus nerve and postinjury inflammatory response</article-title><source>Arch Surg</source><volume>147</volume><fpage>76</fpage><lpage>80</lpage><year>2012</year></element-citation></ref>
<ref id="b201-ol-05-04-1101"><label>201</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiecolt-Glaser</surname><given-names>JK</given-names></name><name><surname>Preacher</surname><given-names>KJ</given-names></name><name><surname>MacCallum</surname><given-names>RC</given-names></name><name><surname>Atkinson</surname><given-names>C</given-names></name><name><surname>Malarkey</surname><given-names>WB</given-names></name><name><surname>Glaser</surname><given-names>R</given-names></name></person-group><article-title>Chronic stress and age-related increases in the proinflammatory cytokine IL-6</article-title><source>Proc Natl Acad Sci USA</source><volume>100</volume><fpage>9090</fpage><lpage>9095</lpage><year>2003</year></element-citation></ref>
<ref id="b202-ol-05-04-1101"><label>202</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madden</surname><given-names>KS</given-names></name><name><surname>Szpunar</surname><given-names>MJ</given-names></name><name><surname>Brown</surname><given-names>EB</given-names></name></person-group><article-title>beta-Adrenergic receptors (beta-AR) regulate VEGF and IL-6 production by divergent pathways in high beta-AR-expressing breast cancer cell lines</article-title><source>Breast Cancer Res Treat</source><volume>130</volume><fpage>747</fpage><lpage>758</lpage><year>2011</year></element-citation></ref>
<ref id="b203-ol-05-04-1101"><label>203</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>EV</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Donovan</surname><given-names>EL</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Gross</surname><given-names>AC</given-names></name><name><surname>Webster</surname><given-names>MJ</given-names></name><name><surname>Barsky</surname><given-names>SH</given-names></name><name><surname>Glaser</surname><given-names>R</given-names></name></person-group><article-title>Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression</article-title><source>Brain Behav Immun</source><volume>23</volume><fpage>267</fpage><lpage>275</lpage><year>2009</year></element-citation></ref>
<ref id="b204-ol-05-04-1101"><label>204</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stathopoulos</surname><given-names>GT</given-names></name><name><surname>Sherrill</surname><given-names>TP</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Sadikot</surname><given-names>RT</given-names></name><name><surname>Yull</surname><given-names>FE</given-names></name><name><surname>Blackwell</surname><given-names>TS</given-names></name><name><surname>Fingleton</surname><given-names>B</given-names></name></person-group><article-title>Host nuclear factor-kappaB activation potentiates lung cancer metastasis</article-title><source>Mol Cancer Res</source><volume>6</volume><fpage>364</fpage><lpage>371</lpage><year>2008</year></element-citation></ref>
<ref id="b205-ol-05-04-1101"><label>205</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paradisi</surname><given-names>A</given-names></name><name><surname>Mehlen</surname><given-names>P</given-names></name></person-group><article-title>Netrin-1, a missing link between chronic inflammation and tumor progression</article-title><source>Cell Cycle</source><volume>9</volume><fpage>1253</fpage><lpage>1262</lpage><year>2010</year></element-citation></ref>
<ref id="b206-ol-05-04-1101"><label>206</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pantel</surname><given-names>K</given-names></name><name><surname>Brakenhoff</surname><given-names>RH</given-names></name></person-group><article-title>Dissecting the metastatic cascade</article-title><source>Nat Rev Cancer</source><volume>4</volume><fpage>448</fpage><lpage>456</lpage><year>2004</year></element-citation></ref>
<ref id="b207-ol-05-04-1101"><label>207</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rafii</surname><given-names>S</given-names></name><name><surname>Lyden</surname><given-names>D</given-names></name><name><surname>Benezra</surname><given-names>R</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Heissig</surname><given-names>B</given-names></name></person-group><article-title>Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?</article-title><source>Nat Rev Cancer</source><volume>2</volume><fpage>826</fpage><lpage>835</lpage><year>2002</year></element-citation></ref>
<ref id="b208-ol-05-04-1101"><label>208</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Direkze</surname><given-names>NC</given-names></name><name><surname>Hodivala-Dilke</surname><given-names>K</given-names></name><name><surname>Jeffery</surname><given-names>R</given-names></name><name><surname>Hunt</surname><given-names>T</given-names></name><name><surname>Poulsom</surname><given-names>R</given-names></name><name><surname>Oukrif</surname><given-names>D</given-names></name><name><surname>Alison</surname><given-names>MR</given-names></name><name><surname>Wright</surname><given-names>NA</given-names></name></person-group><article-title>Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts</article-title><source>Cancer Res</source><volume>64</volume><fpage>8492</fpage><lpage>8495</lpage><year>2004</year></element-citation></ref>
<ref id="b209-ol-05-04-1101"><label>209</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>G</given-names></name><name><surname>Sangai</surname><given-names>T</given-names></name><name><surname>Oda</surname><given-names>T</given-names></name><name><surname>Aoyagi</surname><given-names>Y</given-names></name><name><surname>Hasebe</surname><given-names>T</given-names></name><name><surname>Kanomata</surname><given-names>N</given-names></name><name><surname>Endoh</surname><given-names>Y</given-names></name><name><surname>Okumura</surname><given-names>C</given-names></name><name><surname>Okuhara</surname><given-names>Y</given-names></name><name><surname>Magae</surname><given-names>J</given-names></name><name><surname>Emura</surname><given-names>M</given-names></name><name><surname>Ochiya</surname><given-names>T</given-names></name><name><surname>Ochiai</surname><given-names>A</given-names></name></person-group><article-title>Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction</article-title><source>Biochem Biophys Res Commun</source><volume>309</volume><fpage>232</fpage><lpage>240</lpage><year>2003</year></element-citation></ref>
<ref id="b210-ol-05-04-1101"><label>210</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Psaila</surname><given-names>B</given-names></name><name><surname>Lyden</surname><given-names>D</given-names></name></person-group><article-title>The metastatic niche: adapting the foreign soil</article-title><source>Nat Rev Cancer</source><volume>9</volume><fpage>285</fpage><lpage>293</lpage><year>2009</year></element-citation></ref>
<ref id="b211-ol-05-04-1101"><label>211</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>RN</given-names></name><name><surname>Riba</surname><given-names>RD</given-names></name><name><surname>Zacharoulis</surname><given-names>S</given-names></name><name><surname>Bramley</surname><given-names>AH</given-names></name><name><surname>Vincent</surname><given-names>L</given-names></name><name><surname>Costa</surname><given-names>C</given-names></name><name><surname>MacDonald</surname><given-names>DD</given-names></name><name><surname>Jin</surname><given-names>DK</given-names></name><name><surname>Shido</surname><given-names>K</given-names></name><name><surname>Kerns</surname><given-names>SA</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Hicklin</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Port</surname><given-names>JL</given-names></name><name><surname>Altorki</surname><given-names>N</given-names></name><name><surname>Port</surname><given-names>ER</given-names></name><name><surname>Ruggero</surname><given-names>D</given-names></name><name><surname>Shmelkov</surname><given-names>SV</given-names></name><name><surname>Jensen</surname><given-names>KK</given-names></name><name><surname>Rafii</surname><given-names>S</given-names></name><name><surname>Lyden</surname><given-names>D</given-names></name></person-group><article-title>VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche</article-title><source>Nature</source><volume>438</volume><fpage>820</fpage><lpage>827</lpage><year>2005</year></element-citation></ref>
<ref id="b212-ol-05-04-1101"><label>212</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyan</surname><given-names>JA</given-names></name><name><surname>Broome</surname><given-names>CS</given-names></name><name><surname>Whetton</surname><given-names>AD</given-names></name></person-group><article-title>Neural regulation of bone marrow</article-title><source>Blood</source><volume>92</volume><fpage>2971</fpage><lpage>2973</lpage><year>1998</year></element-citation></ref>
<ref id="b213-ol-05-04-1101"><label>213</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canaani</surname><given-names>J</given-names></name><name><surname>Kollet</surname><given-names>O</given-names></name><name><surname>Lapidot</surname><given-names>T</given-names></name></person-group><article-title>Neural regulation of bone, marrow, and the microenvironment</article-title><source>Front Biosci</source><volume>3</volume><fpage>1021</fpage><lpage>1031</lpage><year>2011</year></element-citation></ref>
<ref id="b214-ol-05-04-1101"><label>214</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benestad</surname><given-names>HB</given-names></name><name><surname>Strom-Gundersen</surname><given-names>I</given-names></name><name><surname>Iversen</surname><given-names>PO</given-names></name><name><surname>Haug</surname><given-names>E</given-names></name><name><surname>Nja</surname><given-names>A</given-names></name></person-group><article-title>No neuronal regulation of murine bone marrow function</article-title><source>Blood</source><volume>91</volume><fpage>1280</fpage><lpage>1287</lpage><year>1998</year></element-citation></ref>
<ref id="b215-ol-05-04-1101"><label>215</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artico</surname><given-names>M</given-names></name><name><surname>Bosco</surname><given-names>S</given-names></name><name><surname>Cavallotti</surname><given-names>C</given-names></name><name><surname>Agostinelli</surname><given-names>E</given-names></name><name><surname>Giuliani-Piccari</surname><given-names>G</given-names></name><name><surname>Sciorio</surname><given-names>S</given-names></name><name><surname>Cocco</surname><given-names>L</given-names></name><name><surname>Vitale</surname><given-names>M</given-names></name></person-group><article-title>Noradrenergic and cholinergic innervation of the bone marrow</article-title><source>Int J Mol Med</source><volume>10</volume><fpage>77</fpage><lpage>80</lpage><year>2002</year></element-citation></ref>
<ref id="b216-ol-05-04-1101"><label>216</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>S</given-names></name><name><surname>Tokunaga</surname><given-names>Y</given-names></name><name><surname>Maeda</surname><given-names>T</given-names></name><name><surname>Kikkawa</surname><given-names>M</given-names></name><name><surname>Hukuda</surname><given-names>S</given-names></name></person-group><article-title>Calcitonin gene-related peptide, substance P, and tyrosine hydroxylase-immunoreactive innervation of rat bone marrows: an immunohistochemical and ultrastructural investigation on possible efferent and afferent mechanisms</article-title><source>J Orthop Res</source><volume>15</volume><fpage>133</fpage><lpage>140</lpage><year>1997</year></element-citation></ref>
<ref id="b217-ol-05-04-1101"><label>217</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Joshi</surname><given-names>DD</given-names></name><name><surname>Hameed</surname><given-names>M</given-names></name><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Gascon</surname><given-names>P</given-names></name><name><surname>Maloof</surname><given-names>PB</given-names></name><name><surname>Mosenthal</surname><given-names>A</given-names></name><name><surname>Rameshwar</surname><given-names>P</given-names></name></person-group><article-title>Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis</article-title><source>Proc Natl Acad Sci USA</source><volume>97</volume><fpage>388</fpage><lpage>393</lpage><year>2000</year></element-citation></ref>
<ref id="b218-ol-05-04-1101"><label>218</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname><given-names>TA</given-names></name><name><surname>Cohen</surname><given-names>MC</given-names></name><name><surname>Rameshwar</surname><given-names>P</given-names></name></person-group><article-title>The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential</article-title><source>Clin Exp Metastasis</source><volume>22</volume><fpage>621</fpage><lpage>628</lpage><year>2005</year></element-citation></ref>
<ref id="b219-ol-05-04-1101"><label>219</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyden</surname><given-names>D</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Dias</surname><given-names>S</given-names></name><name><surname>Costa</surname><given-names>C</given-names></name><name><surname>Blaikie</surname><given-names>P</given-names></name><name><surname>Butros</surname><given-names>L</given-names></name><name><surname>Chadburn</surname><given-names>A</given-names></name><name><surname>Heissig</surname><given-names>B</given-names></name><name><surname>Marks</surname><given-names>W</given-names></name><name><surname>Witte</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Hicklin</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Hackett</surname><given-names>NR</given-names></name><name><surname>Crystal</surname><given-names>RG</given-names></name><name><surname>Moore</surname><given-names>MA</given-names></name><name><surname>Hajjar</surname><given-names>KA</given-names></name><name><surname>Manova</surname><given-names>K</given-names></name><name><surname>Benezra</surname><given-names>R</given-names></name><name><surname>Rafii</surname><given-names>S</given-names></name></person-group><article-title>Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth</article-title><source>Nat Med</source><volume>7</volume><fpage>1194</fpage><lpage>1201</lpage><year>2001</year></element-citation></ref>
<ref id="b220-ol-05-04-1101"><label>220</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajantie</surname><given-names>I</given-names></name><name><surname>Ilmonen</surname><given-names>M</given-names></name><name><surname>Alminaite</surname><given-names>A</given-names></name><name><surname>Ozerdem</surname><given-names>U</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name><name><surname>Salven</surname><given-names>P</given-names></name></person-group><article-title>Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells</article-title><source>Blood</source><volume>104</volume><fpage>2084</fpage><lpage>2086</lpage><year>2004</year></element-citation></ref>
<ref id="b221-ol-05-04-1101"><label>221</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakroborty</surname><given-names>D</given-names></name><name><surname>Chowdhury</surname><given-names>UR</given-names></name><name><surname>Sarkar</surname><given-names>C</given-names></name><name><surname>Baral</surname><given-names>R</given-names></name><name><surname>Dasgupta</surname><given-names>PS</given-names></name><name><surname>Basu</surname><given-names>S</given-names></name></person-group><article-title>Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization</article-title><source>J Clin Invest</source><volume>118</volume><fpage>1380</fpage><lpage>1389</lpage><year>2008</year></element-citation></ref>
<ref id="b222-ol-05-04-1101"><label>222</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name></person-group><article-title>Mesenchymal stem cells in cancer: friends or foes</article-title><source>Cancer Biol Ther</source><volume>7</volume><fpage>252</fpage><lpage>254</lpage><year>2008</year></element-citation></ref>
<ref id="b223-ol-05-04-1101"><label>223</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollard</surname><given-names>JW</given-names></name></person-group><article-title>Tumour-educated macrophages promote tumour progression and metastasis</article-title><source>Nat Rev Cancer</source><volume>4</volume><fpage>71</fpage><lpage>78</lpage><year>2004</year></element-citation></ref>
<ref id="b224-ol-05-04-1101"><label>224</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Condeelis</surname><given-names>J</given-names></name><name><surname>Pollard</surname><given-names>JW</given-names></name></person-group><article-title>Macrophages: obligate partners for tumor cell migration, invasion, and metastasis</article-title><source>Cell</source><volume>124</volume><fpage>263</fpage><lpage>266</lpage><year>2006</year></element-citation></ref>
<ref id="b225-ol-05-04-1101"><label>225</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>BZ</given-names></name><name><surname>Pollard</surname><given-names>JW</given-names></name></person-group><article-title>Macrophage diversity enhances tumor progression and metastasis</article-title><source>Cell</source><volume>141</volume><fpage>39</fpage><lpage>51</lpage><year>2010</year></element-citation></ref>
<ref id="b226-ol-05-04-1101"><label>226</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maestroni</surname><given-names>GJ</given-names></name></person-group><article-title>Catecholaminergic regulation of hematopoiesis in mice</article-title><source>Blood</source><volume>92</volume><fpage>2971</fpage><lpage>2973</lpage><year>1998</year></element-citation></ref>
<ref id="b227-ol-05-04-1101"><label>227</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maestroni</surname><given-names>GJ</given-names></name></person-group><article-title>Dendritic cell migration controlled by alpha 1b-adrenergic receptors</article-title><source>J Immunol</source><volume>165</volume><fpage>6743</fpage><lpage>6747</lpage><year>2000</year></element-citation></ref>
<ref id="b228-ol-05-04-1101"><label>228</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katayama</surname><given-names>Y</given-names></name><name><surname>Battista</surname><given-names>M</given-names></name><name><surname>Kao</surname><given-names>WM</given-names></name><name><surname>Hidalgo</surname><given-names>A</given-names></name><name><surname>Peired</surname><given-names>AJ</given-names></name><name><surname>Thomas</surname><given-names>SA</given-names></name><name><surname>Frenette</surname><given-names>PS</given-names></name></person-group><article-title>Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow</article-title><source>Cell</source><volume>124</volume><fpage>407</fpage><lpage>421</lpage><year>2006</year></element-citation></ref>
<ref id="b229-ol-05-04-1101"><label>229</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendez-Ferrer</surname><given-names>S</given-names></name><name><surname>Lucas</surname><given-names>D</given-names></name><name><surname>Battista</surname><given-names>M</given-names></name><name><surname>Frenette</surname><given-names>PS</given-names></name></person-group><article-title>Haematopoietic stem cell release is regulated by circadian oscillations</article-title><source>Nature</source><volume>452</volume><fpage>442</fpage><lpage>447</lpage><year>2008</year></element-citation></ref>
<ref id="b230-ol-05-04-1101"><label>230</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bissell</surname><given-names>MJ</given-names></name><name><surname>Radisky</surname><given-names>D</given-names></name></person-group><article-title>Putting tumours in context</article-title><source>Nat Rev Cancer</source><volume>1</volume><fpage>46</fpage><lpage>54</lpage><year>2001</year></element-citation></ref>
<ref id="b231-ol-05-04-1101"><label>231</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egeblad</surname><given-names>M</given-names></name><name><surname>Nakasone</surname><given-names>ES</given-names></name><name><surname>Werb</surname><given-names>Z</given-names></name></person-group><article-title>Tumors as organs: complex tissues that interface with the entire organism</article-title><source>Dev Cell</source><volume>18</volume><fpage>884</fpage><lpage>901</lpage><year>2010</year></element-citation></ref>
<ref id="b232-ol-05-04-1101"><label>232</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mareel</surname><given-names>M</given-names></name><name><surname>Oliveira</surname><given-names>MJ</given-names></name><name><surname>Madani</surname><given-names>I</given-names></name></person-group><article-title>Cancer invasion and metastasis: interacting ecosystems</article-title><source>Virchows Arch</source><volume>454</volume><fpage>599</fpage><lpage>622</lpage><year>2009</year></element-citation></ref>
<ref id="b233-ol-05-04-1101"><label>233</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Eliyahu</surname><given-names>S</given-names></name><name><surname>Shakhar</surname><given-names>G</given-names></name><name><surname>Page</surname><given-names>GG</given-names></name><name><surname>Stefanski</surname><given-names>V</given-names></name><name><surname>Shakhar</surname><given-names>K</given-names></name></person-group><article-title>Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors</article-title><source>Neuroimmunomodulat</source><volume>8</volume><fpage>154</fpage><lpage>164</lpage><year>2000</year></element-citation></ref>
<ref id="b234-ol-05-04-1101"><label>234</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuller</surname><given-names>HM</given-names></name><name><surname>Al-Wadei</surname><given-names>HA</given-names></name><name><surname>Ullah</surname><given-names>MF</given-names></name><name><surname>Plummer</surname><given-names>HK</given-names><suffix>III</suffix></name></person-group><article-title>Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention</article-title><source>Carcinogenesis</source><volume>33</volume><fpage>191</fpage><lpage>196</lpage><year>2012</year></element-citation></ref>
<ref id="b235-ol-05-04-1101"><label>235</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasuniwa</surname><given-names>Y</given-names></name><name><surname>Izumi</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>KY</given-names></name><name><surname>Shimajiri</surname><given-names>S</given-names></name><name><surname>Sasaguri</surname><given-names>Y</given-names></name><name><surname>Kawai</surname><given-names>K</given-names></name><name><surname>Kasai</surname><given-names>H</given-names></name><name><surname>Shimada</surname><given-names>T</given-names></name><name><surname>Miyake</surname><given-names>K</given-names></name><name><surname>Kashiwagi</surname><given-names>E</given-names></name><name><surname>Hirano</surname><given-names>G</given-names></name><name><surname>Kidani</surname><given-names>A</given-names></name><name><surname>Akiyama</surname><given-names>M</given-names></name><name><surname>Han</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Ieiri</surname><given-names>I</given-names></name><name><surname>Higuchi</surname><given-names>S</given-names></name><name><surname>Kohno</surname><given-names>K</given-names></name></person-group><article-title>Circadian disruption accelerates tumor growth and angio/stromagenesis through a Wnt signaling pathway</article-title><source>PLoS One</source><volume>5</volume><fpage>e15330</fpage><year>2010</year></element-citation></ref>
<ref id="b236-ol-05-04-1101"><label>236</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arjona</surname><given-names>A</given-names></name><name><surname>Sarkar</surname><given-names>DK</given-names></name></person-group><article-title>Are circadian rhythms the code of hypothalamic-immune communication? Insights from natural killer cells</article-title><source>Neurochem Res</source><volume>33</volume><fpage>708</fpage><lpage>718</lpage><year>2010</year></element-citation></ref>
<ref id="b237-ol-05-04-1101"><label>237</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filipski</surname><given-names>E</given-names></name><name><surname>King</surname><given-names>VM</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Granda</surname><given-names>TG</given-names></name><name><surname>Mormont</surname><given-names>MC</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Claustrat</surname><given-names>B</given-names></name><name><surname>Hastings</surname><given-names>MH</given-names></name><name><surname>Levi</surname><given-names>F</given-names></name></person-group><article-title>Host circadian clock as a control point in tumor progression</article-title><source>J Natl Cancer Inst</source><volume>94</volume><fpage>690</fpage><lpage>697</lpage><year>2002</year></element-citation></ref>
<ref id="b238-ol-05-04-1101"><label>238</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>BL</given-names></name><name><surname>Kiecolt-Glaser</surname><given-names>JK</given-names></name><name><surname>Glaser</surname><given-names>R</given-names></name></person-group><article-title>A biobehavioral model of cancer stress and disease course</article-title><source>Am Psychol</source><volume>49</volume><fpage>389</fpage><lpage>404</lpage><year>1994</year></element-citation></ref>
<ref id="b239-ol-05-04-1101"><label>239</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiegel</surname><given-names>D</given-names></name></person-group><article-title>Mind matters in cancer survival</article-title><source>Psychooncology</source><volume>21</volume><fpage>588</fpage><lpage>593</lpage><year>2012</year></element-citation></ref>
<ref id="b240-ol-05-04-1101"><label>240</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebos</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>CR</given-names></name><name><surname>Cruz-Munoz</surname><given-names>W</given-names></name><name><surname>Bjarnason</surname><given-names>GA</given-names></name><name><surname>Christensen</surname><given-names>JG</given-names></name><name><surname>Kerbel</surname><given-names>RS</given-names></name></person-group><article-title>Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis</article-title><source>Cancer Cell</source><volume>15</volume><fpage>232</fpage><lpage>239</lpage><year>2009</year></element-citation></ref>
<ref id="b241-ol-05-04-1101"><label>241</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rugo</surname><given-names>HS</given-names></name></person-group><article-title>Inhibiting angiogenesis in breast cancer: the beginning of the end or the end of the beginning?</article-title><source>J Clin Oncol</source><volume>30</volume><fpage>898</fpage><lpage>901</lpage><year>2012</year></element-citation></ref>
<ref id="b242-ol-05-04-1101"><label>242</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000E0;ez-Ribes</surname><given-names>M</given-names></name><name><surname>Allen</surname><given-names>E</given-names></name><name><surname>Hudock</surname><given-names>J</given-names></name><name><surname>Takeda</surname><given-names>T</given-names></name><name><surname>Okuyama</surname><given-names>H</given-names></name><name><surname>Vi&#x000F1;als</surname><given-names>F</given-names></name></person-group><article-title>Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis</article-title><source>Cancer Cell</source><volume>15</volume><fpage>220</fpage><lpage>231</lpage><year>2009</year></element-citation></ref>
<ref id="b243-ol-05-04-1101"><label>243</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powe</surname><given-names>DG</given-names></name><name><surname>Entschladen</surname><given-names>F</given-names></name></person-group><article-title>Targeted therapies: Using beta-blockers to inhibit breast cancer progression</article-title><source>Nat Rev Clin Oncol</source><volume>8</volume><fpage>511</fpage><lpage>512</lpage><year>2011</year></element-citation></ref>
<ref id="b244-ol-05-04-1101"><label>244</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barron</surname><given-names>TI</given-names></name><name><surname>Connolly</surname><given-names>RM</given-names></name><name><surname>Sharp</surname><given-names>L</given-names></name><name><surname>Bennett</surname><given-names>K</given-names></name><name><surname>Visvanathan</surname><given-names>K</given-names></name></person-group><article-title>Beta blockers and breast cancer mortality: a population-based study</article-title><source>J Clin Oncol</source><volume>29</volume><fpage>2635</fpage><lpage>2644</lpage><year>2011</year></element-citation></ref>
<ref id="b245-ol-05-04-1101"><label>245</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syromiatnikov</surname><given-names>AV</given-names></name><name><surname>Alistratov</surname><given-names>AV</given-names></name></person-group><article-title>Changes in the efferent impulsation in the vagus nerves during the metastasis of Lewis lung carcinoma in mice</article-title><source>Eksp Onkol</source><volume>11</volume><fpage>47</fpage><lpage>50</lpage><year>1989</year></element-citation></ref>
<ref id="b246-ol-05-04-1101"><label>246</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>ZJ</given-names></name><name><surname>Cho</surname><given-names>CH</given-names></name></person-group><article-title>Neurotransmitters, more than meets the eye--neurotransmitters and their perspectives in cancer development and therapy</article-title><source>Eur J Pharmacol</source><volume>667</volume><fpage>17</fpage><lpage>22</lpage><year>2011</year></element-citation></ref>
<ref id="b247-ol-05-04-1101"><label>247</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuller</surname><given-names>HM</given-names></name><name><surname>Al-Wadei</surname><given-names>HA</given-names></name><name><surname>Majidi</surname><given-names>M</given-names></name></person-group><article-title>GABA B receptor is a novel drug target for pancreatic cancer</article-title><source>Cancer</source><volume>112</volume><fpage>767</fpage><lpage>778</lpage><year>2008</year></element-citation></ref>
<ref id="b248-ol-05-04-1101"><label>248</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>ZF</given-names></name><name><surname>Ho</surname><given-names>DW</given-names></name><name><surname>Lam</surname><given-names>CT</given-names></name><name><surname>Luk</surname><given-names>JM</given-names></name><name><surname>Lum</surname><given-names>CT</given-names></name><name><surname>Yu</surname><given-names>WC</given-names></name><name><surname>Poon</surname><given-names>RT</given-names></name><name><surname>Fan</surname><given-names>ST</given-names></name></person-group><article-title>Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma</article-title><source>Cancer Res</source><volume>65</volume><fpage>219</fpage><lpage>225</lpage><year>2005</year></element-citation></ref>
<ref id="b249-ol-05-04-1101"><label>249</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harburg</surname><given-names>GC</given-names></name><name><surname>Hinck</surname><given-names>L</given-names></name></person-group><article-title>Navigating breast cancer: axon guidance molecules as breast cancer tumor suppressors and oncogenes</article-title><source>J Mammary Gland Biol Neoplasia</source><volume>16</volume><fpage>257</fpage><lpage>270</lpage><year>2011</year></element-citation></ref>
<ref id="b250-ol-05-04-1101"><label>250</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehlen</surname><given-names>P</given-names></name><name><surname>Delloye-Bourgeois</surname><given-names>C</given-names></name><name><surname>Chedotal</surname><given-names>A</given-names></name></person-group><article-title>Novel roles for Slits and netrins: axon guidance cues as anticancer targets?</article-title><source>Nat Rev Cancer</source><volume>11</volume><fpage>188</fpage><lpage>197</lpage><year>2011</year></element-citation></ref>
<ref id="b251-ol-05-04-1101"><label>251</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>DR</given-names></name><name><surname>Cooper</surname><given-names>CR</given-names></name><name><surname>Hurst</surname><given-names>DR</given-names></name><name><surname>Lynch</surname><given-names>CC</given-names></name><name><surname>Martin</surname><given-names>MD</given-names></name><name><surname>Vaidya</surname><given-names>KS</given-names></name><name><surname>VanSaun</surname><given-names>MN</given-names></name><name><surname>Mastro</surname><given-names>AM</given-names></name></person-group><article-title>Metastasis Research Society-American Association For Cancer Research Joint Conference on Metastasis</article-title><source>Cancer Res</source><volume>68</volume><fpage>9578</fpage><lpage>9582</lpage><year>2008</year></element-citation></ref></ref-list></back></article>
